Which of the following is not a standard component of pediatric AML therapy?
---
- (A) Induction chemotherapy with cytarabine and anthracycline
- (B) Consolidation with high-dose cytarabine
- (C) Maintenance therapy with daily oral mercaptopurine and weekly methotrexate
- (D) Hematopoietic stem cell transplantation in selected high-risk cases
💡 Click to Reveal Answer & Nelson Rationale
Option C (Maintenance therapy with daily oral mercaptopurine and weekly methotrexate)
Maintenance therapy with oral mercaptopurine and methotrexate is a hallmark of ALL treatment but is not a part of AML protocols. Pediatric AML relies on intensive chemotherapy blocks (induction and consolidation) and, in selected cases, stem cell transplantation.
Direct/Derived Question (Prognosis) Which of the following is considered a favorable prognostic cytogenetic abnormality in pediatric AML?
---
- (A) Monosomy 7
- (B) FLT3-ITD mutation
- (C) t(8;21)(q22;q22)
- (D) Complex karyotype
💡 Click to Reveal Answer & Nelson Rationale
Option C (t(8;21)(q22;q22))
The translocation t(8;21) is a favorable prognostic marker, most often associated with AML-M2. Children with this abnormality tend to have better responses to chemotherapy and improved survival outcomes compared to other cytogenetic groups.
Which of the following best defines accelerated phase of CML?
---
- (A) Blasts ≥20% in blood or marrow
- (B) Blasts <10%, basophils <20%
- (C) Blasts 10–19% or persistent splenomegaly despite therapy
- (D) Presence of BCR-ABL1 at diagnosis
💡 Click to Reveal Answer & Nelson Rationale
Option C (Blasts 10–19% or persistent splenomegaly despite therapy)
Accelerated phase CML is characterized by 10–19% blasts, persistent or progressive splenomegaly, or cytogenetic evolution despite therapy. It is an intermediate stage between chronic and blast crisis.
Which of the following features is most characteristic of juvenile myelomonocytic leukemia (JMML)?
---
- (A) Presence of BCR-ABL1
- (B) Age <4 years with monocytosis
- (C) Auer rods in blasts
- (D) JAK2 mutation
💡 Click to Reveal Answer & Nelson Rationale
Option B (Age <4 years with monocytosis)
JMML is a rare pediatric myeloproliferative/myelodysplastic overlap disorder, typically seen in children <4 years old, characterized by persistent monocytosis, splenomegaly, and absence of BCR-ABL1. It is frequently associated with RAS pathway mutations.
Which histological subtype of Hodgkin lymphoma is most common in children and adolescents?
---
- (A) Nodular sclerosis
- (B) Mixed cellularity
- (C) Lymphocyte-rich
- (D) Lymphocyte-depleted
💡 Click to Reveal Answer & Nelson Rationale
Option A (Nodular sclerosis)
Nodular sclerosis is the most frequent subtype in children and adolescents, particularly in females, and often presents with mediastinal involvement. Prognosis is generally good.
Which of the following best describes current frontline therapy for pediatric Hodgkin lymphoma?
---
- (A) Surgery alone
- (B) Radiation alone
- (C) Combination chemotherapy with or without low-dose radiation
- (D) High-dose chemotherapy with stem cell transplant
💡 Click to Reveal Answer & Nelson Rationale
Option C (Combination chemotherapy with or without low-dose radiation)
Standard treatment is risk-adapted combination chemotherapy (e.g., ABVD or OEPA regimens), often followed by low-dose involved-field radiation in selected patients. The cure rates exceed 90%.
Which of the following statements regarding CNS involvement and prophylaxis in pediatric NHL is true?
---
- (A) CNS prophylaxis is not required in any subtype
- (B) CNS involvement occurs mainly in Hodgkin lymphoma
- (C) Intrathecal chemotherapy is standard in treatment of pediatric NHL
- (D) Cranial irradiation is the mainstay of CNS prophylaxis
💡 Click to Reveal Answer & Nelson Rationale
Option C (Intrathecal chemotherapy is standard in treatment of pediatric NHL)
CNS prophylaxis is an integral part of NHL therapy in children, usually with intrathecal methotrexate, cytarabine, and hydrocortisone. This prevents relapse, especially in aggressive subtypes like Burkitt and lymphoblastic lymphoma.
Which of the following statements regarding CNS involvement and prophylaxis in pediatric NHL is true?
---
- (A) t(9;22)(q34;q11) – BCR-ABL
- (B) t(14;18)(q32;q21) – BCL2-IGH
- (C) t(8;14)(q24;q32) – MYC-IGH
- (D) t(15;17)(q22;q21) – PML-RARA
💡 Click to Reveal Answer & Nelson Rationale
Option C (t(8;14)(q24;q32) – MYC-IGH)
Burkitt lymphoma is defined by translocation of the MYC oncogene on chromosome 8 to the immunoglobulin heavy chain locus on chromosome 14, resulting in deregulated MYC expression and uncontrolled proliferation.
Which of the following is considered the most important adverse prognostic factor in neuroblastoma?
---
- (A) Age > 18 months at diagnosis
- (B) Elevated urinary VMA/HVA
- (C) Presence of calcification in tumor
- (D) Abdominal site of primary tumor
💡 Click to Reveal Answer & Nelson Rationale
Option A (Age > 18 months at diagnosis)
Age at diagnosis is the strongest prognostic factor. Children <18 months, even with metastatic disease, may do well, whereas those >18 months, particularly with stage 4 disease, have poor prognosis. This reflects tumor biology and host factors.
Which of the following treatment approaches has minimized the use of external beam radiotherapy in intraocular retinoblastoma?
---
- (A) Plaque brachytherapy
- (B) Systemic chemotherapy combined with focal therapy (chemoreduction)
- (C) Enucleation in all cases
- (D) Intravitreal steroids
💡 Click to Reveal Answer & Nelson Rationale
Option B (Systemic chemotherapy combined with focal therapy (chemoreduction))
The combination of systemic chemotherapy (chemoreduction) with local focal therapies such as laser photocoagulation, cryotherapy, or thermotherapy has significantly reduced the need for external beam radiotherapy, which carries a high risk of secondary malignancies in germline RB1 patients.
What is the most common brain tumor in children?
---
- (A) Medulloblastoma
- (B) Pilocytic astrocytoma
- (C) Ependymoma
- (D) Glioblastoma
💡 Click to Reveal Answer & Nelson Rationale
Option B (Pilocytic astrocytoma)
Pilocytic astrocytoma (a low-grade glioma) is the most common brain tumor of childhood. These tumors are often located in the cerebellum but may also occur supratentorially. They are slow-growing and curable with complete resection.
Which of the following is the most typical clinical feature of childhood craniopharyngioma?
---
- (A) Truncal ataxia
- (B) Visual field defects
- (C) Cerebellar signs
- (D) Spinal cord compression
💡 Click to Reveal Answer & Nelson Rationale
Option B (Visual field defects)
Craniopharyngiomas are benign suprasellar tumors arising from Rathke’s pouch remnants. They typically present with bitemporal hemianopia due to optic chiasm compression, growth retardation, and features of hypothalamic–pituitary dysfunction.
Which site is most commonly involved in pediatric osteosarcoma?
---
- (A) Distal femur
- (B) Proximal humerus
- (C) Proximal femur
- (D) Distal radius
💡 Click to Reveal Answer & Nelson Rationale
Option A (Distal femur)
The most common site of osteosarcoma is the metaphysis of long bones near the knee joint (distal femur, proximal tibia). Proximal humerus is the next common site. The metaphyseal predilection is related to rapid bone growth during adolescence.
Which of the following translocations is most commonly seen in infantile acute lymphoblastic leukemia (ALL)?
---
- (A) t(12;21)(p13;q22) – ETV6-RUNX1
- (B) t(4;11)(q21;q23) – MLL-AF4
- (C) t(9;22)(q34;q11.2) – BCR-ABL1
- (D) t(1;19)(q23;p13) – TCF3-PBX1
💡 Click to Reveal Answer & Nelson Rationale
Option B (t(4;11)(q21;q23) – MLL-AF4)
Alterations of the KMT2A (formerly MLL) gene located at chromosome band 11q23 occur in 5% of pediatric ALL, in 70% of infant leukemia (both ALL and AML in patients < 1 year of age), and in most therapy-related leukemias in patients who received topoisomerase II inhibitors. B-ALL pateints with KMT2A rearrangements have significantly poorer treatment outcomes than those of clinically similar patients who do not demonstrate this cytogenetic abnormality, particularly in infant ALL. It is also associated with high leukocyte counts, monocytic features and increased CNS involvement.
You are evaluating a 6-year old child with ALL on maintenance chemotherapy who has frequent mucositis and myelosuppression that needs frequent discontinuation of his treatment. Of the following, the MOST valuable test for this child is –
---
- (A) Complete Blood Count
- (B) Bone marrow study
- (C) Serum folate and B12 levels
- (D) Pharmacogenetic testing of the thiopurine s-methyltransferase(TPMT) and nudix hydrolase 15 (NUDT15) gene
💡 Click to Reveal Answer & Nelson Rationale
Option D (Pharmacogenetic testing of the thiopurine s-methyltransferase(TPMT) and nudix hydrolase 15 (NUDT15) gene)
Pharmacogenetics, the study of the genetic basis for individual differences in response and reaction to medications, is an active area of investigation in ALL. One of the best examples relates to two key enzymes involved in thiopurine metabolism, thiopurine methyltransferase (TPMT) and nudix hydrolase 15 (NUDT15), each of which plays a role in metabolizing parent 6-MP into inactive metabolites. Patients who have two copies of the wild-type TPMT have low rates of adverse consequences (e.g., mucositis, myelosuppression, hepatotoxicity, second malignancies) when treated with standard doses of 6-MP. Conversely, when patients who are homozygous for low-activity enzymatic variants (constituting approximately 0.3% of the population) are treated with the same standard doses, they experience severe myelosuppression and an increased risk of secondary malignancies and hepatotoxicity. TPMT heterozygote patients make up approximately 5% to 10% of the population and demonstrate an intermediate range of toxicities. NUDT15 defective variants were subsequently identified as another source of increased risk of clinical toxicity because they lead to excessive accumulation of thiopurine-active metabolites. TPMT variants are more frequent in patients of European and African ancestry, whereas NUDT15 variants are more frequent in Asian populations. So, in this case, pharmacogenetic testing of TPMT and NUDT genes can help identify patient with homozygous variant or deficient enzyme activity, demanding dose adjustment of 6-MP (6-Meracptopurine) in order to decrease its toxicities such as mucositis and myelosuppression.
Which modality is most important for CNS prophylaxis in modern ALL protocols?
---
- (A) Cranial irradiation
- (B) High-dose methotrexate
- (C) Intrathecal chemotherapy
- (D) Prophylactic cranial surgery
💡 Click to Reveal Answer & Nelson Rationale
Option C (Intrathecal chemotherapy)
Intrathecal MTX ± cytarabine ± hydrocortisone is the cornerstone of CNS prophylaxis. Safe, effective, avoids long-term neurocognitive sequelae of radiation.
Which of the following is a favorable prognostic factor?
---
- (A) Age <1 year
- (B) WBC >50,000/µL at diagnosis
- (C) t(12;21)(p13;q22) ETV6-RUNX1
- (D) KMT2A (MLL) rearrangement
💡 Click to Reveal Answer & Nelson Rationale
Option C (t(12;21)(p13;q22) ETV6-RUNX1)
The ETV6-RUNX1 (t(12;21)) subtype = favorable risk. Common in children 2–10 years, responds well to therapy.
Which of the following statements about metastasis is TRUE?
---
- (A) Ewing sarcoma metastasizes mainly to liver and spleen
- (B) Osteosarcoma commonly metastasizes to the lungs
- (C) Osteosarcoma rarely metastasizes at diagnosis
- (D) Ewing sarcoma never metastasizes to bone marrow
💡 Click to Reveal Answer & Nelson Rationale
Option B (Osteosarcoma commonly metastasizes to the lungs)
Osteosarcoma frequently metastasizes to the lungs, which is the most common site at diagnosis and relapse. Pulmonary nodules are often bilateral and may require metastasectomy along with chemotherapy.
Which histologic subtype of rhabdomyosarcoma has the best prognosis in children?
---
- (A) Embryonal
- (B) Alveolar
- (C) Pleomorphic
- (D) Spindle cell
💡 Click to Reveal Answer & Nelson Rationale
Option A (Embryonal)
Embryonal rhabdomyosarcoma is the most common subtype in children (especially <10 years). It usually arises in head and neck or genitourinary sites and has a relatively favorable prognosis with multimodal therapy.
Which of the following is the strongest poor prognostic factor in hepatoblastoma?
---
- (A) Elevated serum AFP
- (B) PRETEXT IV stage with vascular invasion
- (C) Age <2 years
- (D) Tumor confined to one lobe
💡 Click to Reveal Answer & Nelson Rationale
Option B (PRETEXT IV stage with vascular invasion)
PRETEXT (Pretreatment Extent of Disease) IV with major vascular invasion or extrahepatic spread is associated with poor prognosis in hepatoblastoma. Vascular invasion limits resectability and worsens survival, even with chemotherapy.
Which of the following features indicates a high-risk prognosis in Langerhans cell histiocytosis?
---
- (A) Single skull lesion
- (B) Involvement of liver, spleen, and bone marrow
- (C) Isolated diabetes insipidus
- (D) Unifocal bone disease
💡 Click to Reveal Answer & Nelson Rationale
Option B (Involvement of liver, spleen, and bone marrow)
Multisystem LCH with risk-organ involvement (liver, spleen, bone marrow) carries the worst prognosis and requires systemic chemotherapy. These organs are critical for survival, and their involvement predicts poor outcomes despite therapy.
A child is being evaluated for an inherited cancer predisposition syndrome. The physician explains that some syndromes predispose to malignancy because of defective DNA repair or chromosomal instability. All of the following belong to this category except:
---
- (A) Xeroderma pigmentosum
- (B) Werner syndrome
- (C) Constitutional mismatch repair deficiency syndrome
- (D) Li-Fraumeni syndrome
💡 Click to Reveal Answer & Nelson Rationale
Option D (Li-Fraumeni syndrome)
Li-Fraumeni syndrome is an inherited cancer predisposition syndrome caused by pathogenic variants in TP53, a tumor-suppressor gene. It predisposes to sarcomas, brain tumors, leukemia, adrenocortical carcinoma, and early-onset breast cancer, but it is not classically categorized as a DNA repair/chromosomal instability syndrome.
![[fef7b206_large_table__3__1784310006.png]]
A 14-year-old survivor of childhood acute lymphoblastic leukemia presents several years after completion of therapy with progressive cognitive decline, behavioral changes, and gait difficulty. Magnetic resonance imaging reveals diffuse abnormalities involving the cerebral white matter. Which statement regarding the most likely late complication is correct?
---
- (A) It represents anthracycline-induced cerebral microangiopathy and usually resolves after discontinuation of therapy.
- (B) It represents cisplatin-induced central neurotoxicity and is usually completely reversible with hydration.
- (C) It represents radiation-induced pituitary dysfunction and primarily causes isolated cognitive impairment.
- (D) It represents methotrexate-associated leukoencephalopathy and is often only partially reversible.
💡 Click to Reveal Answer & Nelson Rationale
Option D (It represents methotrexate-associated leukoencephalopathy and is often only partially reversible.)
The child has treatment-related leukoencephalopathy, a late neurologic complication associated particularly with high-dose or intrathecal methotrexate and CNS irradiation. Injury to cerebral white matter may result in progressive cognitive decline, behavioral abnormalities, seizures, gait disturbance, and motor dysfunction. Established leukoencephalopathy is often only partially reversible and may cause persistent neurologic disability. The risk depends on the child’s age at treatment, cumulative treatment exposure, and the use of combined CNS-directed therapies.
A 13-year-old girl treated for advanced Hodgkin lymphoma receives pelvic irradiation and alkylating-agent chemotherapy. She subsequently develops ovarian failure. Which statement regarding radiation-associated gonadal dysfunction is most accurate?
---
- (A) Prepubertal females are at significant risk only when the ovarian radiation dose is ≥20–30 Gy.
- (B) Pubertal females are at significant risk when the ovarian radiation dose is ≥10 Gy.
- (C) Germ cell failure in males generally requires gonadal irradiation of ≥20–30 Gy.
- (D) Androgen insufficiency in males may occur after any dose of pelvic irradiation.
💡 Click to Reveal Answer & Nelson Rationale
Option B (Pubertal females are at significant risk when the ovarian radiation dose is ≥10 Gy.)
Radiation-induced gonadal injury depends on age, sex, dose, and the reproductive structure exposed. In females, clinically important ovarian dysfunction may occur at lower doses after puberty, with a significant risk at doses of ≥10 Gy in pubertal girls, whereas the corresponding threshold in prepubertal girls is approximately ≥15 Gy. Alkylating agents further increase the risk of germ cell failure, delayed or arrested puberty, premature menopause, and infertility. Combined exposure to pelvic irradiation and high cumulative alkylating-agent doses produces the greatest reproductive toxicity.
A 4-year-old child with precursor B-cell acute lymphoblastic leukemia is found to have a constitutional Robertsonian translocation on cytogenetic evaluation. Which chromosomal abnormality is specifically recognized as a predisposing factor for acute lymphoblastic leukemia?
---
- (A) rob(13;14)(q10;q10)
- (B) rob(14;21)(q10;q10)
- (C) rob(15;21)(q10;q10)
- (D) t(12;21)(p13;q22)
💡 Click to Reveal Answer & Nelson Rationale
Option C (rob(15;21)(q10;q10))
A constitutional Robertsonian translocation between chromosomes 15 and 21, rob(15;21)(q10;q10), is a recognized inherited susceptibility factor for childhood acute lymphoblastic leukemia. This constitutional abnormality increases the likelihood of leukemogenic secondary events involving chromosome 21. It should be distinguished from acquired leukemic translocations that are present only in malignant cells and are used primarily for disease classification or prognostication.
**Table: 1Predisposing Factors of Acute Lymphoblastic Leukemia**
![[2217682c_small_table__3__1784353521.png]]
A 6-year-old child is diagnosed with B-cell acute lymphoblastic leukemia. Cytogenetic analysis demonstrates a t(12;21)(p13;q22) translocation. Which of the following genetic subtypes has a prognosis most similar to this patient’s leukemia?
---
- (A) TCF3-HLF translocation t(17;19)(q23;p13)
- (B) TCF3-PBX1 translocation t(1;19)(q23;p13)
- (C) Philadelphia chromosome-like acute lymphoblastic leukemia
- (D) MLL (KMT2A) rearranged acute lymphoblastic leukemia
💡 Click to Reveal Answer & Nelson Rationale
Option B (TCF3-PBX1 translocation t(1;19)(q23;p13))
The t(12;21)(p13;q22) translocation results in the ETV6-RUNX1 fusion and represents one of the most common genetic subtypes of childhood B-cell acute lymphoblastic leukemia. This subtype is associated with a favorable prognosis. Among the listed options, TCF3-PBX1 leukemia is the only subtype that is also categorized as having a favorable prognosis. Recognition of prognostic cytogenetic groups is important because modern risk stratification increasingly relies on genetic abnormalities rather than morphology alone.
A 4-year-old girl is diagnosed with precursor B-cell acute lymphoblastic leukemia. She has no CNS involvement, an initial leukocyte count of 18 × 10⁹/L, hyperdiploidy with trisomy 4 and 10, and undetectable minimal residual disease at the end of induction therapy. Which of the following additional findings would most strongly change her risk category toward an adverse prognosis?
---
- (A) Female sex
- (B) DUX4-rearranged leukemia with ERG deletion
- (C) IKZF1 deletion
- (D) Age 6 years at diagnosis
💡 Click to Reveal Answer & Nelson Rationale
Option C (IKZF1 deletion)
Risk stratification in acute lymphoblastic leukemia integrates demographic, clinical, cytogenetic, genomic, and treatment-response variables. This child possesses multiple favorable prognostic features including age between 1 and 10 years, female sex, low leukocyte count, B-lineage immunophenotype, hyperdiploidy, and negative minimal residual disease. Among the options provided, IKZF1 deletion is a recognized adverse genomic abnormality associated with increased relapse risk and inferior outcomes. The presence of this lesion may outweigh several favorable baseline characteristics and place the patient into a higher-risk category.
**Table: Prognostic Factors for Acute Lymphoblastic Leukemia**
![[77da3858_large_table__4__1784353699.png]]
A 7-year-old child is diagnosed with acute myeloid leukemia. Cytogenetic analysis demonstrates inv(16)(p13q22). Which of the following morphologic findings is most likely to be seen in the bone marrow?
---
- (A) Promyelocytes with numerous Auer rods
- (B) Monoblast predominance with gingival infiltration
- (C) Myeloblasts with abnormal eosinophils containing dysplastic basophilic granules
- (D) Myeloblasts without evidence of differentiation
💡 Click to Reveal Answer & Nelson Rationale
Option C (Myeloblasts with abnormal eosinophils containing dysplastic basophilic granules)
inv(16) results in the CBFB-MYH11 fusion and is one of the favorable-risk cytogenetic abnormalities in pediatric AML. It is characteristically associated with acute myelomonocytic leukemia with abnormal eosinophils. The eosinophils demonstrate abnormal immature granules that often appear basophilic and dysplastic. Recognition of this distinctive morphologic pattern provides an important clue to the underlying cytogenetic abnormality and its favorable prognostic implications.
**Table: Prognostic Implications of Common Chromosomal Abnormalities in Pediatric Acute Myelogenous Leukemia**
![[6ad79438_medium_table__1__1784353897.png]]
A neonate with Down syndrome develops leukocytosis with circulating megakaryoblasts, thrombocytopenia, hepatosplenomegaly, and pleural effusion. The abnormalities resolve spontaneously during infancy. Which statement most accurately describes the subsequent natural history and molecular evolution of this disorder?
---
- (A) Nearly 80% later develop myeloid leukemia after acquiring a GATA1 variant.
- (B) Progression usually occurs in adolescence as acute promyelocytic leukemia.
- (C) About 20% later develop myeloid leukemia at 1–5 years after additional genetic abnormalities.
- (D) Spontaneous resolution excludes later leukemia because GATA1 variants occur only in overt disease.
💡 Click to Reveal Answer & Nelson Rationale
Option C (About 20% later develop myeloid leukemia at 1–5 years after additional genetic abnormalities.)
The neonate has transient abnormal myelopoiesis associated with Down syndrome. Constitutional trisomy 21 expands susceptible fetal liver hematopoietic progenitors, and an acquired GATA1 variant produces the transient megakaryoblastic proliferation. Although the disorder usually resolves spontaneously, about 20% of affected children subsequently acquire additional genetic abnormalities and develop myeloid leukemia of Down syndrome, typically between 1 and 5 years of age. Therefore, spontaneous resolution does not eliminate the need for continued hematologic surveillance.
![[3d713242_1784274678533_1784274678.png]]
A 9-year-old child with precursor B-cell acute lymphoblastic leukemia completed therapy 2 years ago and now presents with headache, vomiting, diplopia, and an isolated sixth cranial nerve palsy. Bone marrow examination is normal. Cerebrospinal fluid analysis demonstrates lymphoblasts. Which of the following is the most appropriate treatment approach?
---
- (A) Intrathecal chemotherapy with craniospinal irradiation followed by allogeneic stem cell transplantation, if required
- (B) Intrathecal chemotherapy with cranial irradiation and intensified CNS surveillance
- (C) Intrathecal chemotherapy with cranial irradiation and systemic chemotherapy
- (D) Systemic chemotherapy followed by allogeneic stem cell transplantation with selective CNS-directed therapy
💡 Click to Reveal Answer & Nelson Rationale
Option C (Intrathecal chemotherapy with cranial irradiation and systemic chemotherapy)
The child has an isolated CNS relapse of acute lymphoblastic leukemia. CNS relapse may present with headache, vomiting, signs of raised intracranial pressure, or isolated cranial nerve palsy, and the diagnosis is confirmed by leukemic cells in the CSF. Treatment requires intrathecal chemotherapy and cranial or craniospinal irradiation to control CNS disease. Systemic chemotherapy is also essential because patients with apparently isolated CNS relapse remain at high risk for subsequent bone marrow relapse.
A neonate with Down syndrome develops transient abnormal myelopoiesis with circulating blasts, thrombocytopenia, jaundice, and hepatosplenomegaly. The clinical abnormalities resolve by 3 months, but flow cytometry continues to detect residual abnormal blasts. Which statement is most accurate?
---
- (A) Persistent blasts indicate failure of spontaneous resolution and mandate immediate stem cell transplantation
- (B) Residual disease at 3 months predicts an increased risk of subsequent myeloid leukemia
- (C) Persistent blasts confirm acute megakaryoblastic leukemia requiring intensive AML chemotherapy
- (D) Residual disease has no prognostic significance once the clinical abnormalities have resolved
💡 Click to Reveal Answer & Nelson Rationale
Option B (Residual disease at 3 months predicts an increased risk of subsequent myeloid leukemia)
Transient abnormal myelopoiesis occurs in approximately 10% of neonates with Down syndrome and is associated with acquired GATA1 variants. Although the clinical and hematologic abnormalities usually resolve within the first 3 months, persistence of abnormal blasts detected by flow cytometry at 3 months is a risk factor for later myeloid leukemia of Down syndrome. Approximately 20–30% of affected children subsequently develop leukemia, often acute megakaryoblastic leukemia, usually within the first 3 years of life.
A 4-month-old infant presents with marked leukocytosis, hepatosplenomegaly, leukemia cutis, tachypnea, and CNS involvement. Immunophenotyping shows pro-B acute lymphoblastic leukemia with absent CD10 expression. Which additional finding would identify the subgroup with the poorest expected survival?
---
- (A) KMT2A rearrangement with leukocyte count of 180,000/μL
- (B) KMT2A rearrangement with age 8 months and leukocyte count of 320,000/μL
- (C) KMT2A rearrangement with age below 6 months and leukocyte count ≥300,000/μL
- (D) Absence of KMT2A rearrangement with age below 6 months and leukocyte count ≥300,000/μL
💡 Click to Reveal Answer & Nelson Rationale
Option C (KMT2A rearrangement with age below 6 months and leukocyte count ≥300,000/μL)
Infant ALL has distinct biologic and clinical features, including B-lineage disease, absent CD10 expression, hyperleukocytosis, extensive tissue infiltration, CNS disease, and leukemia cutis. KMT2A rearrangements, most commonly t(4;11), occur in 70–80% of cases and account for much of the high relapse risk. The highest-risk subgroup consists of infants with KMT2A rearrangement, age below 6 months, and an initial leukocyte count of at least 300,000/μL. Survival in this group is approximately 30%, despite intensive therapy.
A lymph node biopsy from a 14-year-old adolescent with Hodgkin lymphoma demonstrates numerous Reed-Sternberg cells surrounded by lymphocytes, plasma cells, eosinophils, and macrophages. Which of the following findings is most strongly associated with an unfavorable prognosis?
---
- (A) Increased CD8+ T-cell infiltration around Reed-Sternberg cells
- (B) Reactive eosinophilic infiltration with increased IL-6 production
- (C) Germinal-center B-cell origin of Reed-Sternberg cells
- (D) Orderly spread to adjacent lymph node groups
💡 Click to Reveal Answer & Nelson Rationale
Option B (Reactive eosinophilic infiltration with increased IL-6 production)
Hodgkin lymphoma is characterized by a small number of malignant Reed-Sternberg cells surrounded by a rich inflammatory microenvironment. The interaction between Reed-Sternberg cells and surrounding inflammatory cells is critical for tumor growth and survival. Reactive infiltration by eosinophils and CD68-positive macrophages, along with increased production of cytokines such as IL-1, IL-6, and tumor necrosis factor, is associated with a poorer prognosis. These findings reflect a tumor-promoting microenvironment that contributes to disease progression and treatment resistance.
A 16-year-old adolescent with classical Hodgkin lymphoma initially responds to chemotherapy but develops biopsy-proven relapse 8 months after diagnosis. Which of the following is the most appropriate definitive salvage strategy?
---
- (A) PD-1 blockade followed by observation
- (B) Myeloablative chemotherapy with autologous stem cell transplantation
- (C) Reduced-intensity allogeneic stem cell transplantation as first salvage therapy
- (D) Radioimmunotherapy with an anti-CD20 antibody
💡 Click to Reveal Answer & Nelson Rationale
Option B (Myeloablative chemotherapy with autologous stem cell transplantation)
Relapse or progression within 12 months of diagnosis after an initial chemosensitive response represents early relapsed Hodgkin lymphoma and carries a poor prognosis. Such patients are candidates for high-dose myeloablative chemotherapy followed by autologous stem cell transplantation, with or without radiation therapy. This approach provides the standard curative-intent salvage strategy by allowing delivery of otherwise marrow-ablative chemotherapy followed by hematopoietic rescue. Allogeneic transplantation may reduce relapse further through a graft-versus-Hodgkin lymphoma effect, but it is generally considered in more refractory disease or after failure of autologous transplantation because of greater treatment-related risk.
A child has a mature B-cell lymphoma with Burkitt-like morphology and strong CD20 expression. Fluorescence in situ hybridization does not demonstrate rearrangement of MYC, BCL2, or BCL6. Which additional cytogenetic finding would most strongly support the diagnosis?
---
- (A) Gain of chromosome 7 with MYD88 mutation
- (B) Recurrent chromosome 11q abnormalities
- (C) t(14;18) involving IGH and BCL2
- (D) t(8;14) involving MYC and IGH
💡 Click to Reveal Answer & Nelson Rationale
Option B (Recurrent chromosome 11q abnormalities)
The findings suggest MYC-negative Burkitt-like lymphoma, an entity that resembles Burkitt lymphoma morphologically but lacks the defining MYC rearrangement. Instead, these tumors show characteristic chromosome 11q abnormalities and may contain alterations in genes involved in chromatin remodeling and signaling. The diagnosis therefore requires integration of morphology, immunophenotype, and cytogenetic testing rather than reliance on Burkitt-like morphology alone.
![[03df871c_1784275339167_1784275338.png]]
Which of the following pediatric CNS tumors is most strongly associated with Li-Fraumeni syndrome?
---
- (A) Craniopharyngioma
- (B) Choroid plexus carcinoma
- (C) Pilocytic astrocytoma
- (D) Pineal parenchymal tumor
💡 Click to Reveal Answer & Nelson Rationale
Option B (Choroid plexus carcinoma)
Choroid plexus carcinoma is a WHO grade III malignant intraventricular tumor occurring predominantly in infants and young children. TP53 abnormalities have a central role in its pathogenesis, and the tumor has a strong association with Li-Fraumeni syndrome caused by germline TP53 pathogenic variants. Therefore, a child diagnosed with choroid plexus carcinoma should be evaluated for an underlying hereditary cancer-predisposition syndrome.
A 9-year-old child presents with progressive growth failure, delayed puberty, and bitemporal visual field defects. MRI reveals a large heterogeneous suprasellar mass with both solid and cystic components, while CT demonstrates calcifications within the lesion. Molecular analysis identifies a pathogenic variant in CTNNB1. Which of the following statements is most accurate?
---
- (A) The tumor is a papillary craniopharyngioma and is commonly associated with BRAFV600E mutations
- (B) The tumor is an adamantinomatous craniopharyngioma, the predominant subtype in children
- (C) The presence of CTNNB1 mutation predicts malignant transformation and CSF dissemination
- (D) Gross total resection is rarely curative because of the highly infiltrative nature of the tumor
💡 Click to Reveal Answer & Nelson Rationale
Option B (The tumor is an adamantinomatous craniopharyngioma, the predominant subtype in children)
Craniopharyngioma is a WHO grade I tumor accounting for approximately 3–10% of childhood CNS tumors. **Two biologically distinct subtypes exist:**
Adamantinomatous craniopharyngioma (ACP) – the predominant subtype in children and characterized by CTNNB1 mutations.
Papillary craniopharyngioma (PCP) – more common in adults and characterized by BRAFV600E mutations.
The child described has the classic presentation of pediatric craniopharyngioma, including growth failure, delayed sexual maturation, visual impairment, and a heterogeneous suprasellar mass containing both solid and cystic components with calcification. The identification of a CTNNB1 mutation strongly supports the diagnosis of adamantinomatous craniopharyngioma.
Although histologically benign, these tumors frequently cause substantial morbidity because of their proximity to the hypothalamus, optic apparatus, and pituitary gland. Endocrine dysfunction, visual loss, obesity, and panhypopituitarism may occur either from the tumor itself or its treatment.
A 3-year-old child presents with chaotic conjugate eye movements, multifocal myoclonic jerks, truncal ataxia, and marked irritability. Imaging reveals a localized adrenal neuroblastoma that is biologically favorable and completely resected. Which statement regarding the neurologic syndrome is most accurate?
---
- (A) Neurologic manifestations usually resolve completely after tumor resection
- (B) The syndrome is caused by direct cerebellar metastasis from neuroblastoma
- (C) Persistent neuropsychologic sequelae may occur despite successful tumor treatment
- (D) The syndrome indicates aggressive metastatic disease with an unfavorable prognosis
💡 Click to Reveal Answer & Nelson Rationale
Option C (Persistent neuropsychologic sequelae may occur despite successful tumor treatment)
The child has opsoclonus-myoclonus-ataxia syndrome associated with neuroblastoma. It is characterized by chaotic multidirectional eye movements, myoclonus, ataxia, and behavioral disturbance. The syndrome is primarily immune mediated rather than caused by direct tumor infiltration of the cerebellum. The associated neuroblastoma is often localized, well differentiated, and biologically favorable. However, neurologic recovery may be incomplete, and affected children can develop persistent cognitive, behavioral, language, and motor sequelae despite complete tumor removal and favorable oncologic outcome.
A child with favorable-histology Wilms tumor develops an isolated pulmonary relapse 18 months after nephrectomy. Initial treatment consisted of vincristine and actinomycin D without radiotherapy. Which statement regarding prognosis is most accurate?
---
- (A) Prior two-drug therapy predicts a 4-year survival of approximately 80%
- (B) Relapse after 12 months predicts a 4-year survival below 50%
- (C) Lung-only relapse is associated with an unfavorable outcome
- (D) Previous omission of radiotherapy worsens salvage prognosis
💡 Click to Reveal Answer & Nelson Rationale
Option A (Prior two-drug therapy predicts a 4-year survival of approximately 80%)
This child has several favorable prognostic features at relapse: favorable histology, isolated pulmonary recurrence, relapse occurring at least 12 months after nephrectomy, and prior treatment with vincristine and actinomycin D only without radiotherapy. Patients who relapse after receiving only this two-drug regimen have a 4-year survival of approximately 80%. In contrast, children previously treated with vincristine, actinomycin D, and doxorubicin have a lower 4-year survival of approximately 50%, reflecting more treatment-resistant disease and fewer unused salvage options.
A 3-month-old infant is born to a father with documented heritable retinoblastoma due to a pathogenic RB1 mutation. The infant undergoes genetic testing shortly after birth and is found to carry the same mutation. Which of the following is the most appropriate recommendation regarding ophthalmologic surveillance?
---
- (A) Annual ophthalmologic examination until 5 years of age
- (B) Screening only if leukocoria or strabismus develops
- (C) Regular screening ophthalmologic examinations until 7 years of age
- (D) Regular ophthalmologic examinations until 5 years of age after a normal initial examination
💡 Click to Reveal Answer & Nelson Rationale
Option C (Regular screening ophthalmologic examinations until 7 years of age)
Children with a positive family history of retinoblastoma should undergo early ophthalmologic screening while genetic testing is being performed. Once a pathogenic RB1 variant is identified, the child is considered genetically predisposed to retinoblastoma and requires continued surveillance throughout the period of highest tumor risk. A normal ophthalmologic examination during infancy does not exclude future tumor development because retinoblastoma may arise later during childhood. Therefore, regular ophthalmologic examinations are recommended until 7 years of age. In contrast, children with a negative genetic test do not require continued surveillance because they are not at increased inherited risk.
A 7-month-old infant is evaluated for a suprasellar germ cell tumor. Serum AFP is elevated, serum β-hCG is normal, and CSF tumor markers have not yet been obtained. Which of the following interpretations and next steps is most appropriate?
---
- (A) Interpret AFP using age-adjusted values and obtain CSF AFP before assigning the tumor subtype
- (B) Interpret AFP using age-adjusted values and assay both serum and CSF AFP and β-hCG
- (C) Repeat serum AFP after 8 months of age and obtain CSF β-hCG if the lesion progresses
- (D) Use serum AFP with CSF β-hCG because paired measurement of the same marker is unnecessary
💡 Click to Reveal Answer & Nelson Rationale
Option B (Interpret AFP using age-adjusted values and assay both serum and CSF AFP and β-hCG)
AFP is physiologically elevated during infancy and usually declines to adult levels by approximately 8 months of age. Therefore, an elevated AFP value in a 7-month-old infant must be interpreted using age-adjusted reference values and cannot independently establish the tumor subtype. AFP elevation is most strongly associated with endodermal sinus tumors and may be minimally elevated in teratomas, whereas β-hCG may be elevated in choriocarcinoma and germinoma because it is secreted by syncytiotrophoblastic elements. In an intracranial germ cell tumor, both serum and CSF should be assayed for AFP and β-hCG because marker concentrations may differ between the two compartments. These values support diagnosis, risk stratification, assessment of treatment response, and detection of recurrence.
A 10-month-old child presents with a rapidly enlarging abdominal mass. Imaging confirms a hepatic tumor, and serum AFP is markedly elevated. Bilirubin and liver enzymes are normal. Which of the following is the most appropriate diagnostic evaluation?
---
- (A) Contrast-enhanced MRI of the abdomen, serum AFP, and tumor biopsy
- (B) Contrast-enhanced CT of the abdomen, chest CT, serum AFP, and tumor biopsy
- (C) Abdominal MRI, serum β-hCG, hepatitis serology, and bone marrow aspiration
- (D) Abdominal MRI, serum β-hCG, serum AFP, serial imaging and tumor biopsy
💡 Click to Reveal Answer & Nelson Rationale
Option B (Contrast-enhanced CT of the abdomen, chest CT, serum AFP, and tumor biopsy)
The presentation is strongly suggestive of hepatoblastoma. Serum AFP is markedly elevated in almost all hepatoblastomas, although the value must be interpreted according to age because physiologic AFP remains elevated during infancy and declines to adult levels by approximately 1 year. Cross-sectional imaging of the abdomen with contrast-enhanced CT or MRI is required to define the intrahepatic extent of disease, vascular involvement, and potential surgical resectability. Chest CT is essential because the lungs are the most common site of metastasis. Histopathologic confirmation by tumor biopsy is required to establish the diagnosis and guide risk-adapted treatment. Normal bilirubin and liver enzyme levels do not exclude hepatoblastoma and are commonly seen despite a large hepatic tumor.
![[85856378_1784276215258_1784276215.png]]
A 6-year-old boy with bone marrow relapse of precursor B-ALL, refractory to standard re-induction chemotherapy protocols, is being considered for targeted therapy. His leukemic blasts are CD-19 positive. Which of the following targeted therapies is appropriate ?
---
- (A) Tocilizumab
- (B) Inotuzumab Ozogamicin
- (C) Blinatumomab
- (D) Rituximab
💡 Click to Reveal Answer & Nelson Rationale
Option C (Blinatumomab)
Blinatumomab is a BiTE (Bispecific T-cell engager) that binds both CD3 and CD19, bridging T cells in proximity to CD 19-expressing malignant and normal B cells, resulting in perforin-mediated cytotoxic killing of CD19+ cells. Blinatumomab is FDA approved in children with relapsed/refractory B-ALL. This use is based on an international phase 1/2 trial that showed a CR rate of 32% among all patients (with more than half of responders achieving MRD <0.01%) and with a CR rate of 56% in children with a lower disease burden (<50% marrow blasts). Blinatumomab is highly effective at clearing marrow MRD. Primary toxicities of blinatumomab include cytokine-release syndrome (CRS) and neurologic toxicity that manifests with seizures, confusion and aphasia. Incidence and severity of CRS are related to disease burden, with lower rates and severity in the MRD-positive setting. Ongoing clinical trials will determine the optimal integration of blinatumomab in treatment regimens for both relapsed and newly diagnosed B-ALL.
10-year-old boy presents with mediastinal mass and generalized lymphadenopathy. Peripheral smear reveals WBC counts – 1,45,000/cmm with 98% blasts. He is admitted for induction chemotherapy after being diagnosed with T-cell Acute Lymphoblastic Leukemia. He was started on Allopurinol as part of TLS (Tumor Lysis Syndrome) prophylaxis. On day 2 of induction, he developed vomiting, irritability, and decreased urine output. Labs show: K⁺: 6.2 mmol/L, PO₄³⁻: 5.8 mg/dL, Ca²⁺: 6.9 mg/dL, Uric acid: 11 mg/dL, Creatinine: 1.8 mg/dL What is the next best step in management for the patient above?
---
- (A) Administer IV furosemide
- (B) Continue allopurinol and give sodium bicarbonate
- (C) Start Rasburicase
- (D) Start hemodialysis immediately
💡 Click to Reveal Answer & Nelson Rationale
Option C (Start Rasburicase)
The patient is exhibiting clinical features consistent with Tumor Lysis Syndrome (TLS) as defined by the Cairo-Bishop criteria. TLS is classified into two categories: **i) Laboratory Tumor Lysis Syndrome (Lab TLS) **Defined by ≥2 of the following biochemical abnormalities (from baseline), occurring within 3 days before or 7 days after starting chemotherapy:
![[0acb94ee_Untitled_design_-_2025-09-15T135022.683_1757924446.png]]
**ii) Clinical Tumor Lysis Syndrome (Clinical TLS) **Defined as Laboratory TLS plus one or more of the following clinical complications:
![[5a7bf274_Untitled_design_-_2025-09-15T135329.566_1757924624.png]]
Recombinant Urate oxidase - Rasburicase converts uric acid to allantoin, a much more urine-soluble product than uric acid, and does not require alkalinization. Studies demonstrate a fivefold reduction in plasma uric acid levels within hours of a single dose of urate oxidase (0.2 mg/kg). In one study, serum Cr decreased significantly in 24 hours, and no patient developed renal insufficiency or required dialysis. It is the drug of choice in established TLS with elevated uric acid and renal dysfunction, like in this case. It prevents uric acid nephropathy, a major cause of AKI(Acute Kidney Injury) in TLS. It works faster than allopurinol and is effective even if TLS has already begun.
A 5-year-old child presents with fever, lymphadenopathy, and hepatosplenomegaly. Bone marrow shows blasts positive for CD19, CD10, and TdT. Which immunophenotype is most consistent?
---
- (A) Early T-cell precursor ALL
- (B) Precursor B-cell ALL
- (C) Mature B-cell (Burkitt-type) ALL
- (D) Myeloid leukemia with aberrant markers
💡 Click to Reveal Answer & Nelson Rationale
Option B (Precursor B-cell ALL)
Childhood ALL is most commonly precursor B-cell ALL. Typical markers: TdT+, CD19+, CD10+ (CALLA), CD79a+. CALLA positivity is frequent in children and linked with better prognosis.
A 6-year-old with B-ALL has MRD 0.05% after induction. What does this signify?
---
- (A) Complete remission with excellent prognosis
- (B) Persistent MRD with increased relapse risk
- (C) Not clinically relevant (<1%)
- (D) No change in treatment protocol required
💡 Click to Reveal Answer & Nelson Rationale
Option B (Persistent MRD with increased relapse risk)
MRD ≥0.01% is significant. MRD positivity after induction = higher relapse risk → guides intensification of therapy.
A 9-year-old boy with ALL in remission develops isolated testicular enlargement, BM and CNS negative. Which statement is correct?
---
- (A) Testicular relapse is extremely rare
- (B) Isolated testicular relapse has better prognosis than marrow relapse
- (C) Local therapy alone is sufficient
- (D) CNS relapse is more common than testicular relapse
💡 Click to Reveal Answer & Nelson Rationale
Option B (Isolated testicular relapse has better prognosis than marrow relapse)
Testes are a sanctuary site (poor drug penetration). Isolated testicular relapse → intermediate prognosis; better than BM relapse, worse than CNS-only relapse. Requires systemic therapy ± local RT.
A 7-year-old girl presents with fever, easy bruising, and gum hypertrophy. Examination shows hepatosplenomegaly. CBC shows Hb 7.8 g/dL, WBC 45,000/µL, platelets 28,000/µL. Peripheral smear reveals blasts with abundant cytoplasm and prominent granules. Bone marrow aspirate is positive for myeloperoxidase (MPO). What is the most likely diagnosis?
---
- (A) Acute lymphoblastic leukemia (ALL)
- (B) Acute myeloid leukemia (AML)
- (C) Chronic myeloid leukemia
- (D) Aplastic anemia
💡 Click to Reveal Answer & Nelson Rationale
Option B (Acute myeloid leukemia (AML))
This child’s presentation with gingival hypertrophy, hepatosplenomegaly, and MPO-positive blasts is characteristic of AML. The presence of myeloperoxidase distinguishes myeloid from lymphoid blasts, and the clinical sign of gum hypertrophy is especially common in monocytic AML. Such features make AML the most likely diagnosis here.
A 12-year-old boy presents with fatigue and recurrent infections. His blood smear shows blasts with large granules, and Auer rods are identified. Cytogenetic testing reveals t(15;17). Which specific subtype of AML does this represent?
---
- (A) AML with t(8;21)
- (B) AML with inv(16)
- (C) Acute promyelocytic leukemia (APL, AML-M3)
- (D) AML with monosomy 7
💡 Click to Reveal Answer & Nelson Rationale
Option C (Acute promyelocytic leukemia (APL, AML-M3))
The finding of Auer rods and cytogenetic abnormality t(15;17) is pathognomonic for acute promyelocytic leukemia (APL, AML-M3). This subtype is clinically significant because it responds to all-trans retinoic acid (ATRA) and arsenic trioxide, which induce differentiation of malignant promyelocytes.
A 10-year-old boy newly diagnosed with APL presents with sudden respiratory distress, hypoxia, and bleeding. Laboratory tests show prolonged PT and low fibrinogen. Which of the following best explains his complication?
---
- (A) Tumor lysis syndrome
- (B) Disseminated intravascular coagulation (DIC)\
- (C) Hyperleukocytosis syndrome
- (D) Septic shock
💡 Click to Reveal Answer & Nelson Rationale
Option B (Disseminated intravascular coagulation (DIC)\)
DIC is a hallmark complication of APL and is due to release of procoagulant substances from abnormal promyelocytes. The clinical picture of bleeding, respiratory distress, and prolonged coagulation studies fits perfectly with this diagnosis. Recognizing and managing DIC promptly is critical in APL.
A 13-year-old boy presents with fatigue, weight loss, and abdominal fullness. On examination, he has massive splenomegaly. CBC shows WBC 220,000/µL with left-shifted myeloid cells, Hb 9 g/dL, and platelets 550,000/µL. Bone marrow shows marked myeloid hyperplasia. Cytogenetics reveals the BCR-ABL1 fusion gene. What is the most likely diagnosis?
---
- (A) Acute myeloid leukemia
- (B) Chronic myeloid leukemia (CML)
- (C) Juvenile myelomonocytic leukemia (JMML)
- (D) Polycythemia vera
💡 Click to Reveal Answer & Nelson Rationale
Option B (Chronic myeloid leukemia (CML))
The presence of marked leukocytosis with all stages of myeloid maturation, massive splenomegaly, and detection of BCR-ABL1 fusion confirms the diagnosis of CML. Children often present in the chronic phase with splenomegaly and high WBC counts, and the Philadelphia chromosome (t(9;22)) is diagnostic.
A 15-year-old girl with known CML on imatinib presents with bone pain, fever, and anemia. CBC shows 25% blasts in the peripheral smear. What does this finding most likely represent?
---
- (A) Chronic phase CML
- (B) Accelerated phase CML
- (C) Blast crisis of CML
- (D) Relapsed AML
💡 Click to Reveal Answer & Nelson Rationale
Option C (Blast crisis of CML)
Blast crisis is defined by ≥20% blasts in peripheral blood or bone marrow in a patient with CML. It represents progression to an acute leukemia-like phase and is associated with poor prognosis. This patient’s new finding of 25% blasts confirms blast crisis.
Which of the following myeloproliferative neoplasms is most strongly associated with JAK2 V617F mutation in pediatric cases?
---
- (A) Essential Thrombocythemia
- (B) Primary Myelofibrosis
- (C) Chronic Myeloid Leukemia
- (D) Polycythemia Vera
💡 Click to Reveal Answer & Nelson Rationale
Option D (Polycythemia Vera)
Among the classic myeloproliferative neoplasms (MPNs), polycythemia vera (PV) shows the highest association with the JAK2 V617F mutation, even in pediatric patients. While the mutation is less common in children compared to adults, when JAK2 V617F is present, it most strongly correlates with polycythemia vera, driving excessive erythrocyte production through constitutive activation of the JAK-STAT pathway.
A 14-year-old girl with Hodgkin lymphoma has cervical and mediastinal lymphadenopathy. PET-CT shows involvement of para-aortic lymph nodes as well. She has no systemic symptoms. According to Ann Arbor staging, what is the correct stage?
---
- (A) Stage I
- (B) Stage II
- (C) Stage IIl
- (D) Stage IV
💡 Click to Reveal Answer & Nelson Rationale
Option C (Stage IIl)
Stage III disease is defined as involvement of lymph node regions on both sides of the diaphragm (in this case cervical/mediastinal above and para-aortic below) without extranodal spread. Absence of B symptoms makes it Stage IIIA.
A 7-year-old boy presents with abdominal distension and pain for 2 weeks. On examination, a large firm abdominal mass is palpable. He has features of intestinal obstruction. Biopsy reveals sheets of medium-sized lymphoid cells with a high mitotic index, and immunohistochemistry is positive for CD20. What is the most likely diagnosis?
---
- (A) Burkitt lymphoma
- (B) Diffuse large B-cell lymphoma
- (C) T-cell lymphoblastic lymphoma
- (D) Hodgkin lymphoma
💡 Click to Reveal Answer & Nelson Rationale
Option A (Burkitt lymphoma)
Burkitt lymphoma is the most common pediatric NHL, often presenting as a rapidly growing abdominal mass causing obstruction. Histology shows “starry sky” appearance due to macrophages among proliferating B-cells. CD20 positivity confirms B-cell lineage.
A 12-year-old boy presents with cough, dyspnea, and facial swelling that worsens when lying flat. Examination shows engorged neck veins and facial edema. Chest X-ray reveals a large anterior mediastinal mass compressing the trachea. Which subtype of pediatric NHL is most likely?
---
- (A) Burkitt lymphoma
- (B) T-cell lymphoblastic lymphoma
- (C) Anaplastic large cell lymphoma
- (D) Diffuse large B-cell lymphoma
💡 Click to Reveal Answer & Nelson Rationale
Option B (T-cell lymphoblastic lymphoma)
T-cell lymphoblastic lymphoma frequently presents with a large mediastinal mass leading to superior vena cava (SVC) syndrome. It arises from immature T-cells and often requires urgent therapy due to airway compromise.
A 9-month-old infant presents with a firm, irregular, non-tender mass in the left abdomen that crosses the midline. Urinary vanillylmandelic acid (VMA) is elevated. Ultrasound shows a calcified retroperitoneal mass. What is the most likely diagnosis?
---
- (A) Wilms tumor
- (B) Neuroblastoma
- (C) Hepatoblastoma
- (D) Rhabdomyosarcoma
💡 Click to Reveal Answer & Nelson Rationale
Option B (Neuroblastoma)
Neuroblastoma is the most common extracranial solid tumor of infancy. It typically presents as an abdominal mass that is irregular, firm, and often crosses the midline. Calcification within the tumor is common on imaging. Elevated catecholamine metabolites (VMA/HVA) in urine are diagnostic.
A 4-year-old boy presents with periorbital swelling, proptosis, and ecchymotic bluish discoloration around the eyes (“raccoon eyes”). Bone marrow aspirate shows small round blue cells. What is the most likely diagnosis?
---
- (A) Leukemia
- (B) Rhabdomyosarcoma
- (C) Neuroblastoma
- (D) Retinoblastoma
💡 Click to Reveal Answer & Nelson Rationale
Option C (Neuroblastoma)
“Raccoon eyes” due to periorbital ecchymosis are classic for metastatic neuroblastoma to orbital bones. Bone marrow infiltration by small round blue cells supports this diagnosis. Neuroblastoma is notorious for early metastatic spread, particularly to bone and bone marrow.
A 2-year-old boy is brought by parents with a history of white reflex in photographs (“cat’s eye reflex”). Examination reveals leukocoria in the right eye. No family history is present. What is the most likely diagnosis?
---
- (A) Congenital cataract
- (B) Retinoblastoma
- (C) Coats disease
- (D) Retinopathy of prematurity
💡 Click to Reveal Answer & Nelson Rationale
Option B (Retinoblastoma)
Retinoblastoma is the most common intraocular malignancy of childhood. Leukocoria (“cat’s eye reflex”) is the most frequent presenting feature. Although congenital cataract and other causes can also cause leukocoria, in a 2-year-old with no prematurity, retinoblastoma is most likely. Early recognition is crucial for life-saving and vision-saving therapy.
A 9-month-old girl presents with bilateral eye involvement showing leukocoria and strabismus. Genetic testing reveals a germline RB1 mutation. Which of the following is the most important counseling point for the family?
---
- (A) High risk of cataract development in later life
- (B) Increased risk of secondary malignancies, especially osteogenic sarcoma
- (C) No increased risk of tumors outside the eye
- (D) Prognosis is worse than sporadic retinoblastoma
💡 Click to Reveal Answer & Nelson Rationale
Option B (Increased risk of secondary malignancies, especially osteogenic sarcoma)
Germline RB1 mutations predispose to bilateral/multifocal retinoblastoma and confer a lifelong increased risk of secondary malignancies, especially osteogenic sarcoma, soft tissue sarcomas, and melanoma. This risk is further amplified if the patient receives external beam radiotherapy. Lifelong follow-up is mandatory.
A 6-year-old boy presents with headache, vomiting, and unsteadiness for 3 weeks. On examination, he has truncal ataxia and papilledema. MRI brain shows a midline posterior fossa mass compressing the fourth ventricle. Which is the most likely diagnosis?
---
- (A) Cerebellar astrocytoma
- (B) Medulloblastoma
- (C) Ependymoma
- (D) Craniopharyngioma
💡 Click to Reveal Answer & Nelson Rationale
Option B (Medulloblastoma)
Medulloblastoma is the most common malignant brain tumor in children, typically arising in the midline cerebellum. Symptoms of raised intracranial pressure (headache, vomiting, papilledema) combined with truncal ataxia and a midline posterior fossa mass strongly suggest medulloblastoma. These tumors are highly cellular, radiosensitive, and spread via cerebrospinal fluid pathways.
A 12-year-old girl presents with new-onset seizures and progressive weakness in the right upper limb. MRI shows a well-circumscribed lesion in the cerebral hemisphere with cyst and mural nodule. Which tumor is most likely?
---
- (A) Oligodendroglioma
- (B) Pilocytic astrocytoma
- (C) Medulloblastoma
- (D) Germinoma
💡 Click to Reveal Answer & Nelson Rationale
Option B (Pilocytic astrocytoma)
Pilocytic astrocytoma is a WHO Grade I glioma, often supratentorial in older children. Classic imaging shows a cystic lesion with an enhancing mural nodule. These are relatively benign, slow-growing tumors with excellent prognosis after gross total resection.
A 14-year-old boy presents with pain and swelling in the distal femur for 2 months. The pain worsens at night and is not relieved by rest. X-ray shows a destructive lesion with a sunburst pattern and Codman’s triangle. Which is the most likely diagnosis?
---
- (A) Osteosarcoma
- (B) Ewing sarcoma
- (C) Osteoid osteoma
- (D) Chondrosarcoma
💡 Click to Reveal Answer & Nelson Rationale
Option A (Osteosarcoma)
Osteosarcoma is the most common primary malignant bone tumor in children and adolescents. It typically arises in the metaphysis of long bones (especially distal femur and proximal tibia). Classic radiographic findings include a “sunburst” periosteal reaction and Codman’s triangle (periosteal elevation).
An 11-year-old girl presents with fever, pain, and swelling over the mid-shaft of the tibia. X-ray reveals a permeative lesion with layered periosteal reaction (“onion-skin appearance”). Biopsy shows small round blue cells with CD99 positivity. What is the most likely diagnosis?
---
- (A) Ewing sarcoma
- (B) Osteosarcoma
- (C) Langerhans cell histiocytosis
- (D) Rhabdomyosarcoma
💡 Click to Reveal Answer & Nelson Rationale
Option A (Ewing sarcoma)
Ewing sarcoma commonly arises in the diaphysis of long bones and flat bones (pelvis, ribs). Radiology shows onion-skin periosteal reaction. Histology reveals small round blue cells with strong membranous CD99 expression. It may mimic infection but systemic features and aggressive bone destruction help distinguish it.
A 6-year-old boy presents with proptosis and swelling around the left eye. MRI orbit reveals a soft tissue mass arising from the orbit without bony destruction. Biopsy shows small round blue cells positive for desmin and myogenin. What is the most likely diagnosis?
---
- (A) Orbital rhabdomyosarcoma
- (B) Retinoblastoma
- (C) Langerhans cell histiocytosis
- (D) Neuroblastoma
💡 Click to Reveal Answer & Nelson Rationale
Option A (Orbital rhabdomyosarcoma)
Orbital rhabdomyosarcoma is a common pediatric malignancy presenting with rapidly progressive proptosis, swelling, and sometimes displacement of the globe. Histology shows small round blue cells with immunohistochemical positivity for desmin, myogenin, and MyoD1. This confirms muscle-lineage tumor origin.
A 3-year-old boy presents with abdominal distension and a palpable right upper quadrant mass. Serum alpha-fetoprotein (AFP) is markedly elevated. CT abdomen shows a large heterogeneous mass confined to the right lobe of the liver. Which of the following is the most likely diagnosis?
---
- (A) Hepatoblastoma
- (B) Hepatocellular carcinoma
- (C) Neuroblastoma
- (D) Wilms’ tumor
💡 Click to Reveal Answer & Nelson Rationale
Option A (Hepatoblastoma)
Hepatoblastoma is the most common primary liver tumor in children, usually occurring before 5 years of age. It presents with an abdominal mass, hepatomegaly, and significantly elevated AFP (>90% of cases). Imaging typically shows a solitary hepatic mass, most often confined to one lobe.
A 4-year-old boy presents with recurrent otitis media, a painless lytic lesion in the temporal bone, and a papular rash on the trunk. Laboratory findings show mild anemia and thrombocytopenia. Biopsy of the bone lesion reveals cells with coffee-bean–shaped nuclei and eosinophilic cytoplasm, immunohistochemically positive for CD1a and langerin (CD207). What is the most likely diagnosis?
---
- (A) Acute lymphoblastic leukemia
- (B) Langerhans cell histiocytosis
- (C) Ewing sarcoma
- (D) Neuroblastoma
💡 Click to Reveal Answer & Nelson Rationale
Option B (Langerhans cell histiocytosis)
The combination of lytic bone lesion, skin rash, and ear involvement is classic for multisystem LCH. Histopathology confirms LCH with coffee-bean nuclei and immunopositivity for CD1a and langerin. Birbeck granules on electron microscopy (tennis racket–shaped) are pathognomonic, though not always needed for diagnosis.
A 2-year-old girl presents with an abdominal mass arising from the sacrococcygeal region. Serum studies reveal markedly elevated alpha-fetoprotein (AFP). Imaging shows a heterogeneous mass with both cystic and solid components. What is the most likely diagnosis?
---
- (A) Sacrococcygeal teratoma with malignant transformation
- (B) Wilms’ tumor
- (C) Neuroblastoma
- (D) Ovarian cyst
💡 Click to Reveal Answer & Nelson Rationale
Option A (Sacrococcygeal teratoma with malignant transformation)
Sacrococcygeal teratoma is the most common extragonadal germ cell tumor in children, often diagnosed in infancy. Malignant transformation (yolk sac tumor component) is suggested by markedly elevated AFP levels. The location (sacrococcygeal), age, mixed cystic-solid nature, and tumor marker elevation all point towards a malignant germ cell tumor.
A child is being evaluated for a cancer predisposition syndrome after developing a posterior fossa brain tumor. Family history reveals an uncle with osteosarcoma in adolescence and a mother treated for breast cancer at a young age. Which additional childhood malignancy would most strongly fit the same inherited predisposition pattern?
---
- (A) Wilms tumor with WAGR phenotype
- (B) Neuroblastoma with PHOX2B variant
- (C) Osteosarcoma after bilateral retinoblastoma
- (D) Rhabdomyosarcoma in a TP53-related syndrome
💡 Click to Reveal Answer & Nelson Rationale
Option D (Rhabdomyosarcoma in a TP53-related syndrome)
The combination of childhood brain tumor, adolescent osteosarcoma, and early-onset breast cancer suggests Li-Fraumeni syndrome, caused by germline TP53 pathogenic variants. Li-Fraumeni syndrome is associated with multiple childhood cancers, including brain tumors, osteosarcoma, rhabdomyosarcoma, leukemia, and other sarcomas. Among the options, rhabdomyosarcoma in a TP53-related syndrome best fits the same inherited cancer predisposition pattern.
A 9-year-old child is evaluated for marked growth failure and recurrent sinopulmonary infections. He has a photosensitive facial rash with telangiectatic erythema. Cytogenetic testing shows increased chromosomal instability. Which inherited cancer predisposition syndrome is most likely?
---
- (A) Ataxia-telangiectasia
- (B) Bloom syndrome
- (C) Nijmegen breakage syndrome
- (D) Xeroderma pigmentosum
💡 Click to Reveal Answer & Nelson Rationale
Option B (Bloom syndrome)
This child most likely has Bloom syndrome, an inherited cancer predisposition syndrome caused by defective DNA repair with chromosomal instability. The key clues are marked growth failure, recurrent infections, and photosensitive telangiectatic erythema. These features help distinguish Bloom syndrome from other DNA repair disorders that may also predispose to childhood malignancy.
A child with acute lymphoblastic leukemia is found to have a chromosomal translocation involving ETV6 and RUNX1. The oncologist explains that this is an oncogene-activating event caused by formation of a chimeric protein. Which chromosomal translocation is most likely present?
---
- (A) t(9;22)
- (B) t(12;21)
- (C) t(8;14)
- (D) t(15;17)
💡 Click to Reveal Answer & Nelson Rationale
Option B (t(12;21))
The ETV6::RUNX1 fusion is caused by t(12;21) and is associated with acute lymphoblastic leukemia. It represents oncogene activation through chromosomal translocation producing a chimeric protein. This is a high-yield pediatric leukemia association.
A child with a renal tumor is found to have absence of the iris on examination and congenital genitourinary abnormalities. Developmental delay is also present. Genetic testing shows a chromosomal deletion that includes a tumor suppressor gene involved in renal and gonadal development. Which chromosomal abnormality best explains this syndrome?
---
- (A) 11p13 deletion involving WT1
- (B) 11p15 imprinting abnormality
- (C) 13q14 deletion involving RB1
- (D) 5q deletion involving APC
💡 Click to Reveal Answer & Nelson Rationale
Option A (11p13 deletion involving WT1)
This child has WAGR syndrome, characterized by Wilms tumor, aniridia, genitourinary anomalies, and developmental delay. It is caused by deletion of chromosome 11p13, typically involving the WT1 gene. The question is framed around the gene and chromosomal region rather than directly asking the syndrome name.
A 12-year-old child is evaluated for macrocephaly, multiple mucocutaneous papillomatous lesions, and gastrointestinal hamartomatous polyps. Family history reveals early-onset thyroid carcinoma and breast cancer in relatives. A PTEN hamartoma tumor syndrome is suspected. Which malignancy is classically associated with this syndrome?
---
- (A) Retinoblastoma
- (B) Medulloblastoma
- (C) Thyroid carcinoma
- (D) Wilms tumor
💡 Click to Reveal Answer & Nelson Rationale
Option C (Thyroid carcinoma)
PTEN hamartoma tumor syndromes include Cowden syndrome, Bannayan-Riley-Ruvalcaba syndrome, Proteus syndrome, and Proteus-like syndromes. These disorders are associated with pathogenic variants involving the PTEN/PI3K-AKT pathway and predispose to malignancies including breast, thyroid, renal, colon cancer, and melanoma.
A child with high-risk neuroblastoma is started on an immunotherapy directed against a disialoganglioside expressed on tumor cells. Which targeted agent is being used?
---
- (A) Brentuximab
- (B) Dinutuximab
- (C) Blinatumomab
- (D) Bevacizumab
💡 Click to Reveal Answer & Nelson Rationale
Option B (Dinutuximab)
Dinutuximab is a monoclonal antibody directed against GD2 and is used in neuroblastoma. GD2 is highly expressed on neuroblastoma cells, making it an important therapeutic target in pediatric oncology.
A child with plexiform neurofibroma associated with neurofibromatosis type 1 is planned for targeted therapy. The oncologist chooses a drug that inhibits the MAPK/MEK. Which agent is most appropriate?
---
- (A) Rituximab
- (B) Brentuximab
- (C) Selumetinib
- (D) Imatinib
💡 Click to Reveal Answer & Nelson Rationale
Option C (Selumetinib)
Selumetinib is a targeted agent that inhibits the MAPK/MEK pathway and is used for plexiform neurofibroma, especially in patients with NF1. This is distinct from monoclonal antibodies such as rituximab, which targets CD20, and brentuximab, which targets CD30.
**Table: Tyrosine Kinase Inhibitors and Monoclonal Antibodies for Pediatric Cancers
**
![[00aab83e_large_table__8__1784354064.png]]
A child receiving chemotherapy for acute lymphoblastic leukemia develops severe jaw pain, constipation, ileus, and peripheral neuropathy. Blood counts are relatively preserved compared with other cytotoxic agents. Which drug is most likely responsible?
---
- (A) Cytarabine
- (B) Vincristine
- (C) Doxorubicin
- (D) Cyclophosphamide
💡 Click to Reveal Answer & Nelson Rationale
Option B (Vincristine)
This presentation is typical of vincristine toxicity. Vincristine inhibits microtubule formation and is commonly used in ALL and several pediatric solid tumors. Its high-yield adverse effects are peripheral neuropathy, jaw pain, constipation, ileus, inappropriate ADH secretion, and local cellulitis if extravasation occurs. Unlike many other chemotherapeutic agents, vincristine causes minimal myelosuppression, which is an important distinguishing clue.
A child receiving chemotherapy for a CNS tumor develops delayed bone marrow suppression several weeks after treatment. Over subsequent cycles, the child develops progressive respiratory symptoms, and evaluation suggests pulmonary fibrosis. Which chemotherapeutic agent is most likely responsible?
---
- (A) Carmustine
- (B) Etoposide
- (C) Tretinoin
- (D) Vincristine
💡 Click to Reveal Answer & Nelson Rationale
Option A (Carmustine)
Carmustine is a nitrosourea used in CNS tumors and lymphomas. It carbamylates DNA and inhibits DNA synthesis. A high-yield toxicity pattern is delayed myelosuppression, typically occurring several weeks after exposure, along with pulmonary fibrosis. This delayed marrow toxicity helps distinguish it from many other chemotherapy adverse-effect patterns.
A child with leukemia is receiving an antimetabolite that is incorporated into DNA and RNA after activation through the purine salvage pathway. The same figure places this drug near purine metabolism rather than at microtubules or topoisomerase-mediated DNA breaks. Which drug is most likely being described?
---
- (A) Thioguanine
- (B) 6-Mercaptopurine
- (C) Cytarabine
- (D) Methotrexate
💡 Click to Reveal Answer & Nelson Rationale
Option B (6-Mercaptopurine)
6-Mercaptopurine is a purine analog used in acute lymphoblastic leukemia. It inhibits purine synthesis and is incorporated into nucleic acids after activation through the purine salvage pathway. This places it close to purine metabolism in the chemotherapy mechanism figure.
![[a7a312ea_1784279009195_1784279009.png]]
A child with non-Hodgkin lymphoma receives chemotherapy and later develops hemorrhagic cystitis despite adequate hydration. The treating team emphasizes that this toxicity can be prevented by giving a uroprotective agent with future doses. Which drug is most likely responsible?
---
- (A) Ifosfamide
- (B) Doxorubicin
- (C) Cytarabine
- (D) Vinblastine
💡 Click to Reveal Answer & Nelson Rationale
Option A (Ifosfamide)
This child most likely received ifosfamide, an alkylating agent that inhibits DNA synthesis. It is used in non-Hodgkin lymphoma, Wilms tumor, and soft tissue sarcoma. A high-yield toxicity is hemorrhagic cystitis, which can be prevented with mesna. Ifosfamide can also cause myelosuppression, pulmonary fibrosis, inappropriate ADH secretion, and CNS dysfunction.
A 7-year-old child is receiving radiation therapy for a solid tumor. Which adverse effect of radiation therapy is most likely?
---
- (A) Alopecia
- (B) Mucositis
- (C) Somnolence
- (D) Dermatitis
💡 Click to Reveal Answer & Nelson Rationale
Option D (Dermatitis)
Dermatitis is the most common general adverse effect of radiation therapy because skin is usually included in the radiation field. It typically appears over the irradiated area and may become more evident during the later part of the treatment course.
A 10-year-old child with chemotherapy-refractory B-cell acute lymphoblastic leukemia receives an autologous cellular immunotherapy. Within 48 hours, the child develops high-grade fever, hypotension, hypoxia, generalized myalgias, confusion, and seizures. The symptoms are more severe because of a high pretreatment leukemic burden. Which treatment is most appropriate?
---
- (A) Siltuximab
- (B) Tocilizumab
- (C) Brentuximab
- (D) Rituximab
💡 Click to Reveal Answer & Nelson Rationale
Option B (Tocilizumab)
The child has cytokine release syndrome following CAR-T-cell therapy. CRS results from rapid activation of engineered T cells and secondary immune cells after recognition of tumor antigens, producing a marked inflammatory cytokine response. Interleukin-6 is a major mediator of fever, hypotension, vascular leak, hypoxia, myalgias, and multiorgan dysfunction. Neurologic manifestations such as confusion and seizures may occur concurrently. A high pretreatment leukemic burden increases the magnitude of immune activation and is associated with more severe CRS. Tocilizumab blocks the interleukin-6 receptor and is the preferred targeted treatment for clinically significant CRS.
![[c41006b4_1784279351020_1784279351.png]]
A 7-year-old child treated for medulloblastoma is undergoing long-term survivorship follow-up. Audiometry demonstrates bilateral high-frequency sensorineural hearing loss despite normal otoscopic findings. Which of the following treatment exposures is associated with the highest risk for development of this late complication?
---
- (A) Cranial irradiation affecting the ear >30 Gy in a child who received cisplatin 280 mg/m²
- (B) Cranial irradiation affecting the ear >20 Gy in a child who received cisplatin 280 mg/m²
- (C) Cranial irradiation affecting the ear >30 Gy in a child who received cisplatin 360 mg/m²
- (D) Cranial irradiation affecting the ear >20 Gy in a child who received cisplatin 360 mg/m²
💡 Click to Reveal Answer & Nelson Rationale
Option C (Cranial irradiation affecting the ear >30 Gy in a child who received cisplatin 360 mg/m²)
The child has treatment-related sensorineural hearing loss, a recognized late effect of childhood cancer therapy. Cisplatin causes dose-dependent cochlear injury, predominantly affecting high-frequency hearing, and the risk is greater at a cumulative dose of approximately 360 mg/m². Radiation involving the auditory apparatus further increases the risk, particularly when the dose affecting the ear exceeds 30 Gy. The combination of high-dose cisplatin and high-dose irradiation produces additive ototoxicity and therefore carries the greatest risk of permanent hearing impairment.
A childhood cancer survivor develops progressive exertional dyspnea, dry cough, reduced total lung capacity, and decreased diffusing capacity several years after completing chemotherapy. All of the following chemotherapeutic agents are recognized causes of this late pulmonary complication except:
---
- (A) Bleomycin
- (B) Busulfan
- (C) Carmustine
- (D) Cisplatin
💡 Click to Reveal Answer & Nelson Rationale
Option D (Cisplatin)
The child has treatment-related interstitial lung injury progressing to pulmonary fibrosis and restrictive lung disease. Bleomycin, busulfan, and nitrosoureas such as carmustine and lomustine are important causes of delayed pulmonary toxicity. The risk increases with higher cumulative doses and when pulmonary-toxic chemotherapy is combined with mantle, mediastinal, whole-lung, or total-body irradiation. Cisplatin is not a characteristic cause of pulmonary fibrosis; its major late toxicities are nephrotoxicity and sensorineural hearing loss.
A 9-year-old child with relapsed B-cell acute lymphoblastic leukemia is found to have persistent measurable residual disease despite intensive chemotherapy. The oncology team plans treatment with a bispecific T-cell engager that simultaneously binds CD3 on T lymphocytes and CD19 on leukemic blasts. Which of the following agents is most likely being administered?
---
- (A) Inotuzumab ozogamicin
- (B) Blinatumomab
- (C) Rituximab
- (D) Daratumumab
💡 Click to Reveal Answer & Nelson Rationale
Option B (Blinatumomab)
Blinatumomab is a bispecific T-cell engager that binds CD3 on cytotoxic T lymphocytes and CD19 on B-cell acute lymphoblastic leukemia cells. This dual binding brings T cells into close proximity with leukemic blasts, resulting in targeted immune-mediated cytotoxicity. The drug is particularly useful in relapsed disease and in patients with persistent measurable residual disease. Understanding the distinction between surface antigen targets and the mechanism of action of newer immunotherapies has become increasingly important in modern ALL management.
![[e2636b03_1784279661469_1784279662.png]]
All of the following inherited syndromes are recognized to increase the risk of childhood acute myeloid leukemia except:
---
- (A) Bloom syndrome
- (B) Kostmann syndrome
- (C) Neurofibromatosis type 1
- (D) Patau syndrome
💡 Click to Reveal Answer & Nelson Rationale
Option D (Patau syndrome)
Bloom syndrome, Kostmann syndrome, and neurofibromatosis type 1 are recognized inherited conditions associated with increased susceptibility to childhood AML. Bloom syndrome causes genomic instability, Kostmann syndrome is a congenital neutropenia syndrome with risk of clonal myeloid transformation, and neurofibromatosis type 1 predisposes to myeloid malignancies. Patau syndrome is not listed among the established inherited predisposition syndromes for pediatric AML.
A 14-year-old boy with newly diagnosed chronic myeloid leukemia has a leukocyte count of 280,000/mm³, painful splenomegaly, headache, and transient visual blurring. BCR-ABL1–directed therapy has been initiated, but an immediate response is not expected. Which additional treatment is most appropriate for short-term control of his current manifestations?
---
- (A) Hydroxyurea until the tyrosine kinase inhibitor produces cytoreduction
- (B) Immediate HLA-matched stem cell transplantation during chronic phase
- (C) Anthracycline-based induction chemotherapy for presumed blast crisis
- (D) Discontinuation of the tyrosine kinase inhibitor after leukocyte normalization
💡 Click to Reveal Answer & Nelson Rationale
Option A (Hydroxyurea until the tyrosine kinase inhibitor produces cytoreduction)
The child has chronic-phase CML with symptomatic hyperleukocytosis while awaiting the effect of BCR-ABL1–directed therapy. Hydroxyurea provides gradual cytoreduction and can control disabling or threatening manifestations such as headache, visual symptoms, and splenic discomfort until the tyrosine kinase inhibitor becomes effective. It is a temporary adjunct rather than definitive therapy. Long-term treatment remains a tyrosine kinase inhibitor such as imatinib, dasatinib, or nilotinib.
A 9-year-old child with newly diagnosed acute myeloid leukemia achieves morphologic remission after induction chemotherapy. Cytogenetic analysis demonstrates monosomy 7, and measurable residual disease remains detectable. What is the most appropriate post-remission strategy?
---
- (A) Repeat induction until MRD negativity
- (B) Chemotherapy with transplant at relapse
- (C) Allogeneic transplant in first remission
- (D) High-dose cytarabine with MRD surveillance
💡 Click to Reveal Answer & Nelson Rationale
Option C (Allogeneic transplant in first remission)
Post-remission therapy in AML is determined by both biologic risk and treatment response. Monosomy 7 is an adverse cytogenetic abnormality associated with poor outcomes when treated with chemotherapy alone. Persistent measurable residual disease after induction further identifies a population at very high risk of relapse. Therefore, these patients are considered candidates for allogeneic stem cell transplantation in first remission, as this approach offers the best opportunity for durable disease control.
A 7-year-old child with precursor B-cell acute lymphoblastic leukemia has an initial leukocyte count of 42,000/μL and hyperdiploidy with trisomy 4 and 10. At the end of induction, bone marrow shows morphologic remission, but measurable residual disease is 0.02%. Which statement is most accurate?
---
- (A) Standard-risk therapy is appropriate because age and leukocyte count meet NCI criteria
- (B) Favorable cytogenetics outweigh the residual disease detected after induction
- (C) Treatment should be intensified because day-29 MRD exceeds 0.01%
- (D) Maintenance may begin because marrow blasts are below 5%
💡 Click to Reveal Answer & Nelson Rationale
Option C (Treatment should be intensified because day-29 MRD exceeds 0.01%)
This child has favorable baseline features, including age between 1 and 10 years, leukocyte count below 50,000/μL, and hyperdiploidy with trisomy 4 and 10. However, measurable residual disease at the end of induction is a powerful independent predictor of relapse. Day-29 marrow MRD above 0.01% is associated with shorter event-free survival across all risk categories. Therefore, persistent MRD overrides otherwise favorable clinical and cytogenetic features and warrants treatment intensification.
A 6-year-old child with precursor B-cell acute lymphoblastic leukemia achieves complete morphologic remission after induction therapy. Which phase of treatment is primarily responsible for reducing the incidence of subsequent CNS relapse from historical rates approaching 60% to less than 5%?
---
- (A) Induction with early intrathecal therapy and systemic remission induction
- (B) Consolidation with repeated intrathecal therapy and intensive systemic chemotherapy
- (C) Delayed intensification with CNS-penetrant multiagent chemotherapy
- (D) Maintenance with prolonged mercaptopurine-methotrexate therapy and intermittent CNS prophylaxis
💡 Click to Reveal Answer & Nelson Rationale
Option B (Consolidation with repeated intrathecal therapy and intensive systemic chemotherapy)
Following remission induction, consolidation therapy focuses on eradication of residual leukemic cells within sanctuary sites, particularly the CNS. During this phase, repeated intrathecal chemotherapy is administered along with continued intensive systemic therapy. This strategy has dramatically reduced the incidence of CNS relapse from historical rates as high as 60% to less than 5%. The success of modern ALL therapy is largely attributable to effective CNS-directed treatment delivered during consolidation.
All of the following genes are commonly altered in juvenile myelomonocytic leukemia except:
---
- (A) PTPN11
- (B) NF1
- (C) CBL
- (D) RUNX1
💡 Click to Reveal Answer & Nelson Rationale
Option D (RUNX1)
Juvenile myelomonocytic leukemia is driven predominantly by constitutive activation of the RAS signaling pathway. Approximately 90% of patients have pathogenic alterations involving PTPN11, NRAS, KRAS, NF1, or CBL. These abnormalities promote uncontrolled proliferation of myelomonocytic progenitors. RUNX1 is not among the characteristic RAS-pathway genes commonly altered in JMML.
Patients with neurofibromatosis type 1 and Noonan syndrome have a predilection for this type of leukemia because they have germline mutations involved in RAS signaling. JMML in the setting of Noonan syndrome and CBL syndrome is unique, with most patients having a spontaneous resolution. However, for other patients with JMML, stem cell transplantation offers the best opportunity for cure, although outcomes are still poor.
A 6-month-old infant with acute leukemia presents with violaceous skin nodules, hepatosplenomegaly, respiratory distress, and cerebrospinal fluid involvement. Bone marrow examination shows myeloid and monocytic differentiation. Which subtype is most likely?
---
- (A) Acute myeloblastic leukemia with maturation
- (B) Acute myelomonocytic leukemia
- (C) Acute megakaryoblastic leukemia
- (D) KMT2A-rearranged pro-B acute lymphoblastic leukemia
💡 Click to Reveal Answer & Nelson Rationale
Option B (Acute myelomonocytic leukemia)
Infant AML has distinctive clinical features and commonly presents with extramedullary disease, particularly leukemia cutis and CNS involvement. Among AML subtypes in infancy, acute myelomonocytic leukemia is characteristically associated with combined granulocytic and monocytic differentiation and can produce marked tissue infiltration. The presence of violaceous skin nodules, hepatosplenomegaly, respiratory symptoms, and CSF involvement is therefore highly compatible with this subtype.
The major diagnostic mimic is infant ALL. Infant ALL is almost always of B-cell lineage, is commonly CD10-negative pro-B disease, and demonstrates KMT2A rearrangement in 70–80% of cases, most often t(4;11). It may also present with hyperleukocytosis, organomegaly, CNS disease, leukemia cutis, and diffuse pulmonary infiltration causing tachypnea. However, infant ALL is composed of large irregular lymphoblasts without myeloid and monocytic differentiation. Therefore, the lineage findings on bone marrow examination favor acute myelomonocytic leukemia despite the overlapping clinical presentation.
An adolescent with Hodgkin lymphoma has enlarged cervical and mediastinal lymph nodes, along with splenic involvement. There is no extranodal organ infiltration. According to the Lugano classification, which stage is most appropriate?
---
- (A) Stage II
- (B) Stage II bulky
- (C) Stage III
- (D) Stage IV
💡 Click to Reveal Answer & Nelson Rationale
Option C (Stage III)
Stage III Hodgkin lymphoma is defined by lymph node involvement on both sides of the diaphragm or by lymph nodes above the diaphragm with splenic involvement. In this patient, cervical and mediastinal nodes are located above the diaphragm, while splenic disease extends the involvement below the diaphragm. The absence of noncontiguous extranodal organ involvement excludes stage IV disease.
**Table: Lugano Classification for Hodgkin Lymphoma***
![[71c767c4_medium_table__2__1784354277.png]]
A 15-year-old adolescent with refractory classical Hodgkin lymphoma is planned for single-agent therapy with an antibody–drug conjugate directed against an antigen abundantly expressed on Reed-Sternberg cells. Which agent is most appropriate?
---
- (A) Polatuzumab vedotin targeting CD79b with monomethyl auristatin E
- (B) Brentuximab vedotin targeting CD30 with monomethyl auristatin E
- (C) Inotuzumab ozogamicin targeting CD22 with calicheamicin
- (D) Gemtuzumab ozogamicin targeting CD33 with calicheamicin
💡 Click to Reveal Answer & Nelson Rationale
Option B (Brentuximab vedotin targeting CD30 with monomethyl auristatin E)
Brentuximab vedotin is an antibody–drug conjugate directed against CD30, which is strongly expressed on Reed-Sternberg cells in classical Hodgkin lymphoma. It combines a chimeric anti-CD30 monoclonal antibody with the antimitotic payload monomethyl auristatin E. After internalization, the payload disrupts microtubule function and causes tumor-cell death. It has substantial single-agent activity in refractory Hodgkin lymphoma and is also incorporated into selected frontline regimens.
This agent shows impressive efficacy as single- agent therapy in refractory HL and is being tested as part of up- front therapy combined with chemotherapy in patients with newly diagnosed disease where pediatric trials incorporating brentuximab to replace vincristine in the OEPA/COPDac backbone have demonstrated overall safety, tolerability, and efficacy with 97% event- free survival (EFS) and the ability to limit radiation to involved node radiation sites only. Furthermore, the combination of both brentuximab and rituximab, together with AVD chemotherapy in newly diagnosed patients, has shown 100% efficacy while allowing for the elimination of toxic alkylator agents, topoisomerase inhibitors, bleomycin, and any radiation in the majority of patients.
A 17-year-old adolescent with multiply relapsed classical Hodgkin lymphoma receives a monoclonal antibody that restores antitumor T-cell activity by blocking a negative co-stimulatory receptor involved in T-cell exhaustion. Which drug is most appropriate?
---
- (A) Rituximab
- (B) Brentuximab vedotin
- (C) Nivolumab
- (D) Ibritumomab tiuxetan
💡 Click to Reveal Answer & Nelson Rationale
Option C (Nivolumab)
Nivolumab is a monoclonal antibody that blocks programmed death protein 1, a negative co-stimulatory receptor expressed on T cells. Binding of PD-1 to PD-L1 suppresses T-cell activation and produces T-cell exhaustion, allowing Hodgkin lymphoma cells to evade immune surveillance. PD-1 blockade restores T-cell responsiveness and has shown significant activity in relapsed or refractory Hodgkin lymphoma. Pembrolizumab acts through the same pathway and is another important PD-1 inhibitor.
A 9-year-old child is diagnosed with unresected stage III Burkitt lymphoma. Bone marrow and cerebrospinal fluid examinations are negative for lymphoma. Which treatment strategy is most appropriate?
---
- (A) FAB/LMB Group A therapy with two chemotherapy cycles
- (B) FAB/LMB Group B therapy with rituximab and no maintenance
- (C) FAB/LMB Group C therapy with rituximab and maintenance
- (D) ALL-type chemotherapy for 2 years with CNS prophylaxis
💡 Click to Reveal Answer & Nelson Rationale
Option B (FAB/LMB Group B therapy with rituximab and no maintenance)
Unresected intermediate-risk Burkitt lymphoma without bone marrow or CNS involvement is treated with FAB/LMB Group B therapy. Contemporary COG protocols add rituximab to the chemotherapy backbone because Burkitt lymphoma expresses CD20. Mature B-cell lymphomas are rapidly proliferating but highly chemosensitive; therefore, treatment is short and intensive and does not include prolonged maintenance. Group A therapy is reserved for completely resected localized disease, whereas Group C therapy is used for high-risk disease with bone marrow or CNS involvement.
**Table: Treatment Regimens and Outcome by Disease Staging**
![[9ac57886_large_table__9__1784354555.png]]
A 12-year-old child is diagnosed with anaplastic large cell lymphoma. Cytogenetic analysis demonstrates t(2;5), and molecular testing confirms a constitutively active tyrosine kinase fusion. Which targeted agent is most appropriate?
---
- (A) Lorlatinib
- (B) Brentuximab vedotin
- (C) Crizotinib
- (D) Blinatumomab
💡 Click to Reveal Answer & Nelson Rationale
Option C (Crizotinib)
The t(2;5) translocation in pediatric anaplastic large cell lymphoma produces the NPM-ALK fusion gene, resulting in constitutive activation of anaplastic lymphoma kinase signaling. Crizotinib is an oral tyrosine kinase inhibitor with activity against ALK and directly targets this molecular driver. Although ALCL also expresses CD30 and may respond to brentuximab vedotin, the presence of a confirmed ALK fusion makes an ALK-directed inhibitor the most specific targeted treatment.
A 13-year-old boy presents with a large anterior mediastinal mass causing cough and dyspnea. Bone marrow evaluation reveals leukemic involvement, and cerebrospinal fluid examination is positive for malignant cells. Which subtype of childhood non-Hodgkin lymphoma is most consistent with this pattern of disease?
---
- (A) Diffuse large B-cell lymphoma
- (B) Burkitt lymphoma
- (C) Lymphoblastic lymphoma
- (D) Anaplastic large cell lymphoma
💡 Click to Reveal Answer & Nelson Rationale
Option C (Lymphoblastic lymphoma)
Lymphoblastic lymphoma (LBL) typically arises from precursor T lymphocytes and has biologic features similar to acute lymphoblastic leukemia. A hallmark clinical presentation is a symptomatic mediastinal mass, often producing cough, dyspnea, or superior mediastinal syndrome. LBL also has a characteristic tendency to disseminate to the bone marrow, central nervous system, and testes. Therefore, the combination of a mediastinal mass with both marrow and CNS involvement strongly favors LBL over the other major pediatric NHL subtypes.
A 10-year-old child with Burkitt lymphoma has a completely resected ileocecal tumor with involvement of associated mesenteric lymph nodes. There is no bone marrow or CNS involvement. According to the International Pediatric Non-Hodgkin Lymphoma Staging System (IPNHLSS), the disease should be classified as:
---
- (A) Stage I
- (B) Stage II
- (C) Stage III
- (D) Stage IV
💡 Click to Reveal Answer & Nelson Rationale
Option B (Stage II)
A primary gastrointestinal tumor, usually arising in the ileocecal region, with or without involvement of associated mesenteric lymph nodes is classified as Stage II when it is completely resectable. This is an important staging exception because regional mesenteric nodal involvement does not automatically classify the disease as Stage III. The absence of bone marrow and CNS involvement also excludes Stage IV disease.
**Table: International Pediatric Non-Hodgkin Lymphoma Staging System (IPNHLSS)***
![[e5d5bf3e_large_table__10__1784354872.png]]
A child with non-Hodgkin lymphoma has no morphologic bone marrow involvement on aspiration. Flow cytometry detects a small clonal lymphoma population in the marrow. How should this finding be recorded in the International Pediatric Non-Hodgkin Lymphoma Staging System?
---
- (A) BMm positive
- (B) BMi positive
- (C) BMc positive
- (D) BMmol positive
💡 Click to Reveal Answer & Nelson Rationale
Option B (BMi positive)
The IPNHLSS records bone marrow involvement according to the method by which disease is detected. BMm denotes morphologic involvement, BMi denotes immunophenotypic involvement detected by immunohistochemistry or flow cytometry, BMc denotes cytogenetic or FISH detection, and BMmol denotes molecular detection by PCR-based techniques. This distinction is important because the revised system recognizes low-level marrow disease that may be missed by morphology alone.
**Table: Additional IPNHLSS Information***
![[a33b4179_medium_table__3__1784355289.png]]
A child with Burkitt lymphoma completes therapy. FDG-PET is negative, bone marrow and CSF are free of disease, and no new lesions are identified. However, a residual mediastinal mass persists on CT scan without morphologic evidence of viable lymphoma. According to the International Pediatric Non-Hodgkin Lymphoma Response Criteria (IPNHLRC), the response is best classified as:
---
- (A) Complete response (CR)
- (B) Complete response, biopsy negative (CRb)
- (C) Complete response, unconfirmed (CRu)
- (D) Partial response (PR)
💡 Click to Reveal Answer & Nelson Rationale
Option C (Complete response, unconfirmed (CRu))
According to the IPNHLRC, complete response unconfirmed (CRu) is assigned when a residual mass persists after treatment but demonstrates no morphologic evidence of active lymphoma, with no new lesions and no evidence of disease in the bone marrow or CSF. This category recognizes that residual radiographic abnormalities may represent fibrosis or necrotic tissue rather than viable tumor.
![[49749809_1784281603866_1784281606.png]]
A 9-year-old boy is newly diagnosed with Burkitt lymphoma and has a markedly elevated lactate dehydrogenase level, hyperuricemia, and bulky abdominal disease. The oncology team plans pharmacologic prophylaxis for tumor lysis syndrome. Which of the following is a contraindication to the preferred urate-lowering agent in this patient?
---
- (A) Chronic kidney disease
- (B) Hyperphosphatemia
- (C) Glucose-6-phosphate dehydrogenase deficiency
- (D) Extensive bone marrow involvement
💡 Click to Reveal Answer & Nelson Rationale
Option C (Glucose-6-phosphate dehydrogenase deficiency)
Children with newly diagnosed Burkitt lymphoma and lymphoblastic lymphoma are at particularly high risk for tumor lysis syndrome (TLS) because of their high tumor burden and rapid cell turnover. High-risk patients require vigorous hydration, close electrolyte monitoring, and urate-lowering therapy. Rasburicase, a recombinant urate oxidase, is preferred in patients at high risk of TLS because it rapidly degrades uric acid. However, rasburicase is contraindicated in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency because it can precipitate severe hemolysis and methemoglobinemia.
A 14-year-old boy with newly diagnosed advanced-stage Burkitt lymphoma is started on standard multiagent chemotherapy. Which additional agent is currently considered standard-of-care because it significantly improves both event-free survival and overall survival in pediatric mature B-cell NHL?
---
- (A) Brentuximab vedotin
- (B) Rituximab
- (C) Polatuzumab vedotin
- (D) Blinatumomab
💡 Click to Reveal Answer & Nelson Rationale
Option B (Rituximab)
Rituximab is a monoclonal antibody directed against CD20, which is expressed on mature B-cell lymphomas including Burkitt lymphoma and diffuse large B-cell lymphoma. A large international randomized trial demonstrated that adding rituximab to standard multiagent chemotherapy significantly improved outcomes in advanced-stage pediatric mature B-cell NHL. Three-year event-free survival improved from 82% with chemotherapy alone to 94% with rituximab-containing therapy. As a result, rituximab is now considered standard-of-care for advanced-stage pediatric mature B-cell NHL.
A 13-year-old child with newly diagnosed T-cell lymphoblastic lymphoma receives an acute lymphoblastic leukemia–type regimen. Which additional agent is increasingly incorporated into upfront therapy because of its selective T-lymphocyte toxicity and ability to reduce CNS relapse?
---
- (A) Cladribine
- (B) Nelarabine
- (C) Fludarabine
- (D) Pentostatin
💡 Click to Reveal Answer & Nelson Rationale
Option B (Nelarabine)
Nelarabine is a purine analog with selective toxicity toward T lymphocytes and has an important role in T-lineage malignancies. In clinical trials involving predominantly T-ALL with a smaller T-LBL cohort, nelarabine improved 4-year disease-free survival and reduced the risk of CNS relapse. Although a statistically significant benefit was not demonstrated separately in the smaller advanced T-LBL subgroup, this cohort was underpowered, and many centers now incorporate nelarabine into frontline therapy for T-LBL. Treatment otherwise follows an ALL-like approach with induction, consolidation, interim maintenance, reinduction for advanced disease, and prolonged maintenance with 6-mercaptopurine and methotrexate.
A child with relapsed mature B-cell non-Hodgkin lymphoma is enrolled in a trial using an oral agent that selectively inhibits the delta isoform of phosphoinositide 3-kinase and disrupts lymphoid-cell survival signaling. Which drug is being administered?
---
- (A) Obinutuzumab
- (B) Ibrutinib
- (C) Idelalisib
- (D) Polatuzumab vedotin
💡 Click to Reveal Answer & Nelson Rationale
Option C (Idelalisib)
Idelalisib is a selective inhibitor of the delta isoform of phosphoinositide 3-kinase. PI3K-delta is important in B-cell receptor–mediated survival and proliferation of lymphoid cells. Inhibition of this pathway reduces prosurvival signaling in malignant B cells. Idelalisib is being investigated alone and with chemotherapy as a novel reinduction approach in relapsed non-Hodgkin lymphoma.
A 13-year-old child with a familial cancer-predisposition syndrome develops a cerebellar medulloblastoma. Genetic evaluation identifies a pathogenic variant involving chromosome 5q21. Which gene is most likely affected?
---
- (A) PTCH1
- (B) APC
- (C) PTEN
- (D) TP53
💡 Click to Reveal Answer & Nelson Rationale
Option B (APC)
The combination of medulloblastoma and a pathogenic variant at chromosome 5q21 is characteristic of Turcot syndrome associated with the APC gene. Turcot syndrome may arise through different molecular pathways. APC-associated disease is linked particularly to medulloblastoma, whereas mismatch repair gene abnormalities such as hMLH1 or hPMS2 are more commonly associated with glioblastoma. This gene-tumor distinction is important because the same clinical syndrome can have different CNS manifestations depending on the underlying mutation.
**Table:** Familial Syndromes Associated with Pediatric Brain Tumors
![[586ed863_medium_table__4__1784355496.png]]
A 6-year-old child presents with 4 months of progressive unsteadiness, headache, diplopia, and facial asymmetry. MRI shows an enhancing fourth ventricular mass extending laterally toward the cerebellopontine region. Which diagnosis is most likely?
---
- (A) Medulloblastoma
- (B) Cerebellar astrocytoma
- (C) Brainstem glioma
- (D) Ependymoma
💡 Click to Reveal Answer & Nelson Rationale
Option D (Ependymoma)
Ependymoma commonly arises from the fourth ventricle and may extend laterally toward the cerebellopontine region. Children typically present over several months with features of raised intracranial pressure and posterior fossa dysfunction, including headache, unsteadiness, diplopia, and facial asymmetry. The lateral extension from a fourth ventricular mass is an important imaging clue that helps distinguish ependymoma from other posterior fossa tumors.
**Table:** Posterior Fossa Tumors of Childhood
![[6f2f50e6_large_table__11__1784357331.png]]
A 2-year-old child undergoes near-total resection of a medulloblastoma. Postoperative MRI of the brain and spine shows no dissemination, and CSF cytology is negative. Which treatment strategy is most appropriate?
---
- (A) Reduced-dose craniospinal irradiation with tumor-bed boost and chemotherapy
- (B) High-dose chemotherapy with peripheral stem cell reinfusion to defer radiation
- (C) Focal tumor-bed irradiation with maintenance chemotherapy
- (D) Standard-dose craniospinal irradiation after hematopoietic recovery
💡 Click to Reveal Answer & Nelson Rationale
Option B (High-dose chemotherapy with peripheral stem cell reinfusion to defer radiation)
Children younger than 3 years with medulloblastoma are managed as a separate therapeutic group because the developing brain is highly vulnerable to craniospinal irradiation. Even when the disease is localized and postoperative staging shows M0 status, conventional craniospinal radiation can produce profound and permanent late effects, including microcephaly, learning disability, reduced intelligence, impaired processing speed, growth failure, hypothyroidism, hypogonadism, delayed puberty, and an increased risk of second malignancies.
For this reason, treatment in very young children aims to delay or avoid radiation by using intensive systemic chemotherapy. High-dose chemotherapy followed by peripheral stem cell reinfusion permits administration of myeloablative drug doses while restoring hematopoiesis afterward. The objective is to control microscopic residual disease during the period of greatest neurodevelopmental vulnerability and reserve radiation for persistent or recurrent disease when necessary.
The absence of spinal dissemination and negative CSF cytology are favorable findings, but they do not justify observation or surgery alone because medulloblastoma is a malignant embryonal tumor with a strong tendency for neuraxial spread and recurrence. In older children with M0 disease and gross total resection, reduced-dose craniospinal irradiation may be appropriate, but in a 2-year-old child age is the dominant treatment-modifying factor. Therefore, high-dose chemotherapy with stem cell reinfusion is preferred to defer craniospinal irradiation.
A 2-year-old child is diagnosed with neuroblastoma and presents with persistent watery diarrhea that is refractory to conventional therapy. There is no evidence of gastrointestinal infection or malabsorption. Which paraneoplastic syndrome is most likely responsible for this presentation?
---
- (A) Pepper syndrome
- (B) Hutchinson syndrome
- (C) Kerner-Morrison syndrome
- (D) Opsoclonus-myoclonus-ataxia syndrome
💡 Click to Reveal Answer & Nelson Rationale
Option C (Kerner-Morrison syndrome)
Kerner-Morrison syndrome is a classic paraneoplastic manifestation of neuroblastoma caused by tumor secretion of vasoactive intestinal peptides (VIP). Excess VIP results in profuse secretory watery diarrhea that may lead to dehydration, electrolyte disturbances, and failure to thrive. Neuroblastomas associated with this syndrome are often biologically favorable.
**Table:** Syndromes Due to or Associated with Neuroblastoma
![[b5342244_medium_table__5__1784357470.png]]
A child with neuroblastoma has a family history of pheochromocytoma and paraganglioma affecting multiple generations. Which germline pathogenic variant is most likely to underlie this cancer-predisposition syndrome?
---
- (A) PHOX2B pathogenic variant
- (B) MAX pathogenic variant
- (C) HRAS pathogenic variant
- (D) NF1 pathogenic variant
💡 Click to Reveal Answer & Nelson Rationale
Option B (MAX pathogenic variant)
Familial pheochromocytoma-paraganglioma syndrome is an autosomal dominant cancer-predisposition disorder associated with pathogenic variants in MAX and other susceptibility genes. MAX participates in transcriptional regulation with MYC, and loss of normal MAX function may promote neural crest–derived tumor formation. Neuroblastoma, pheochromocytoma, and paraganglioma share a neural crest origin, making the family history an important clue to the underlying germline abnormality.
**Syndromes Predisposing to Neuroblastoma**
![[0e792cf0_medium_table__6__1784357597.png]]
An 11-month-old infant is diagnosed with neuroblastoma. Imaging reveals a localized adrenal primary tumor with metastases limited to the liver and skin. Bone marrow examination shows minimal involvement (<10% malignant cells), and there is no cortical bone disease. According to the International Neuroblastoma Staging System (INSS), what is the most appropriate stage?
---
- (A) Stage 3
- (B) Stage 4
- (C) Stage 4S
- (D) Stage 2B
💡 Click to Reveal Answer & Nelson Rationale
Option C (Stage 4S)
Stage 4S (“special”) neuroblastoma is a favorite NEET SS concept. It is defined as a localized primary tumor (stage 1, 2A, or 2B) in an infant with dissemination restricted to the liver, skin, and/or minimal bone marrow involvement, without the widespread metastatic pattern seen in conventional stage 4 disease.
Despite the presence of metastatic disease, stage 4S behaves biologically differently from stage 4 neuroblastoma and often undergoes spontaneous regression. Consequently, survival exceeds 80–90%, making it one of the most paradoxical staging categories in pediatric oncology.
The key discriminator is that metastases to liver, skin, and minimal bone marrow in an infant = Stage 4S, whereas bone, cortical bone, or extensive marrow disease would qualify as Stage 4.
**Table:** International Neuroblastoma Staging System
![[5681591a_medium_table__7__1784357784.png]]
A 4-year-old child with neuroblastoma has bone and bone marrow metastases with segmental chromosomal aberrations. Which treatment approach is most appropriate for this prognostic category?
---
- (A) Induction chemotherapy, surgery, focal radiotherapy, and autologous stem cell rescue
- (B) Moderate-intensity chemotherapy with autologous stem cell rescue and isotretinoin
- (C) Dose-intensive multimodal therapy with autologous stem cell rescue, isotretinoin, and anti-GD2 immunotherapy
- (D) Moderate-intensity chemotherapy with surgery and anti-GD2 immunotherapy
💡 Click to Reveal Answer & Nelson Rationale
Option C (Dose-intensive multimodal therapy with autologous stem cell rescue, isotretinoin, and anti-GD2 immunotherapy)
The presence of bone and bone marrow metastases in a 4-year-old child, together with segmental chromosomal aberrations, indicates high-risk neuroblastoma. Treatment requires a dose-intensive multimodal approach. Initial therapy includes intensive induction chemotherapy, followed by surgical resection of the primary tumor and focal radiotherapy to the primary and resistant metastatic sites. Consolidation consists of myeloablative chemotherapy with autologous hematopoietic stem cell rescue. This is followed by isotretinoin, which promotes differentiation of residual neuroblastoma cells, and anti-GD2 immunotherapy with dinutuximab, which targets GD2 expressed on neuroblastoma cells. This sequence improves disease control, although the long-term survival of high-risk disease remains approximately 40–50%.
**Table:** Phenotypic and Genetic Features of Neuroblastoma, Treatment, and Survival According to Prognostic Category
![[06745c73_medium_table__8__1784357970.png]]
A 3-year-old child with high-risk neuroblastoma completes induction chemotherapy, surgical resection, high-dose chemotherapy with autologous stem cell rescue, and focal radiotherapy. Which additional post-transplant therapy has been shown to improve 2-year event-free survival by targeting an antigen widely expressed on neuroblastoma cells?
---
- (A) Rituximab with 13-cis-retinoic acid
- (B) Dinutuximab with 13-cis-retinoic acid
- (C) Brentuximab vedotin with isotretinoin
- (D) Blinatumomab with tandem transplantation
💡 Click to Reveal Answer & Nelson Rationale
Option B (Dinutuximab with 13-cis-retinoic acid)
High-risk neuroblastoma requires multimodal therapy consisting of intensive induction chemotherapy, resection of the residual primary tumor, high-dose chemotherapy with autologous stem cell rescue, focal radiotherapy, and post-transplant therapy directed against minimal residual disease. Dinutuximab is a monoclonal antibody against GD2, a disialoganglioside expressed widely on neuroblastoma cells. When added to 13-cis-retinoic acid after autologous stem cell transplantation, dinutuximab improved 2-year event-free survival from 46.5% to 66.5%. Isotretinoin promotes differentiation of residual neuroblastoma cells, while anti-GD2 immunotherapy enhances immune-mediated tumor-cell destruction.
A child with ambiguous genitalia and diffuse mesangial sclerosis is found to have a pathogenic variant affecting exon 8 or 9 of WT1. Which Wilms tumor predisposition syndrome is most likely?
---
- (A) Frasier syndrome
- (B) Denys-Drash syndrome
- (C) WAGR syndrome
- (D) Beckwith-Wiedemann syndrome
💡 Click to Reveal Answer & Nelson Rationale
Option B (Denys-Drash syndrome)
Denys-Drash syndrome is a WT1-associated Wilms tumor predisposition syndrome caused by pathogenic variants involving exon 8 or 9 of WT1. The characteristic phenotype includes ambiguous genitalia and diffuse mesangial sclerosis, often leading to early renal failure. The estimated risk of Wilms tumor exceeds 75%, making recognition of this syndrome important for surveillance and management. The combination of nephropathy, disordered sexual development, and a high Wilms tumor risk is the key diagnostic pattern.
**Table:** Wilms Tumor Predisposing Conditions
![[7d8930f9_medium_table__10__1784358191.png]]
A child with unilateral favorable-histology Wilms tumor undergoes molecular risk assessment. Which genetic finding is most strongly associated with inferior survival despite favorable histology?
---
- (A) Loss of heterozygosity at 1p and 16q
- (B) Gain of chromosome 1q
- (C) Loss of imprinting at 11p15
- (D) Somatic TP53 pathogenic variant
💡 Click to Reveal Answer & Nelson Rationale
Option B (Gain of chromosome 1q)
Gain of chromosome 1q is associated with inferior survival in unilateral favorable-histology Wilms tumor and is an important adverse molecular prognostic marker. In contrast, loss of heterozygosity at 1p and 16q is classically associated with an increased risk of recurrence. Molecular abnormalities at 11p15 are common in Wilms tumor and frequently produce biallelic IGF2 expression, but they do not carry the same specific prognostic implication as 1q gain in this setting. TP53 abnormalities are linked primarily to anaplastic histology, which itself confers an unfavorable prognosis.
A child with Wilms tumor undergoes nephrectomy. Which of the following findings would still permit classification as Stage II rather than Stage III?
---
- (A) Microscopic residual tumor at the surgical margin
- (B) Regional lymph node metastasis
- (C) Renal sinus vessel invasion with complete resection
- (D) Intraoperative tumor spillage
💡 Click to Reveal Answer & Nelson Rationale
Option C (Renal sinus vessel invasion with complete resection)
Stage II Wilms tumor extends beyond the kidney but is completely resected with negative margins and negative regional lymph nodes. Penetration of the renal capsule or invasion of renal sinus vessels may be present and still qualify as Stage II, provided complete excision has been achieved. The key distinction from Stage III is the absence of residual abdominal tumor, tumor spillage, prior biopsy, regional nodal metastasis, or peritoneal implants.
**Table:** Children’s Oncology Group Staging of Wilms Tumor
![[25c51c58_medium_table__11__1784358315.png]]
A child with a renal mass undergoes nephrectomy, and histopathology confirms clear cell sarcoma of the kidney. Which additional staging evaluation is most appropriate because of the characteristic metastatic pattern of this tumor?
---
- (A) Bone scan and brain imaging
- (B) MIBG scan and bone marrow aspiration
- (C) Whole-body PET scan and lumbar puncture
- (D) Skeletal survey and spinal MRI
💡 Click to Reveal Answer & Nelson Rationale
Option A (Bone scan and brain imaging)
Clear cell sarcoma of the kidney has a distinctive tendency to metastasize to bone and may also spread to the brain. Therefore, once histopathology confirms clear cell sarcoma, staging should include a bone scan to detect skeletal metastases and CT or MRI of the brain to identify intracranial spread. This metastatic pattern differs from typical Wilms tumor, in which the lungs are the most common metastatic site and routine bone or brain imaging is not required unless another renal tumor subtype is suspected.
A 20-month-old child with unilateral favorable-histology Wilms tumor undergoes nephrectomy. The tumor is confined to the kidney, completely resected, and weighs 480 g. Regional lymph nodes are negative. Which treatment is most appropriate?
---
- (A) Nephrectomy
- (B) Regimen EE4A for 18 weeks
- (C) Regimen DD4A for 12 weeks
- (D) Regimen M with for 16 weeks
💡 Click to Reveal Answer & Nelson Rationale
Option A (Nephrectomy)
This child fulfills the criteria for very low-risk Wilms tumor: age younger than 2 years, stage I disease, favorable histology, and tumor weight less than 550 g. In this subgroup, nephrectomy alone is sufficient, with a 4-year event-free survival of approximately 90% and overall survival of 100%. Avoiding chemotherapy prevents unnecessary toxicity without compromising survival.
The child does not require vincristine and actinomycin D because those drugs are used for most stage I and II favorable-histology tumors outside the very low-risk subgroup. Radiotherapy is also unnecessary because there is no residual disease, tumor rupture, positive lymph node, or metastatic spread.
A 5-year-old child with favorable-histology Wilms tumor has pulmonary metastases at diagnosis. After nephrectomy and 6 weeks of DD4A, chest imaging shows persistent lung nodules. Which treatment modification is most appropriate?
---
- (A) Continue DD4A with lung irradiation
- (B) Switch to EE4A with lung irradiation and add etoposide
- (C) Switch to EE4A with lung irradiation and add cyclophosphamide
- (D) Add cyclophosphamide and etoposide to DD4A
💡 Click to Reveal Answer & Nelson Rationale
Option D (Add cyclophosphamide and etoposide to DD4A)
The child has stage IV favorable-histology Wilms tumor with an incomplete pulmonary response after 6 weeks of DD4A. DD4A consists of vincristine, doxorubicin, and actinomycin D. Persistent lung nodules after 6 weeks identify a higher-risk subgroup requiring treatment intensification. Cyclophosphamide and etoposide are added to the existing DD4A backbone to form Regimen M. Lung irradiation is also generally required when pulmonary metastases fail to show a rapid complete response. The same intensified regimen is used in stage III or IV disease with loss of heterozygosity at both 1p and 16q.
A 15-year-old adolescent presents with painless gross hematuria and a renal mass. Histopathology confirms renal cell carcinoma. Which molecular abnormality is most characteristic of the commonest pediatric subtype?
---
- (A) WT1 pathogenic variant involving chromosome 11p13
- (B) TFE3 or TFEB gene translocation
- (C) Loss of heterozygosity at chromosomes 1p and 16q
- (D) SMARCB1 deletion involving chromosome 22q11
💡 Click to Reveal Answer & Nelson Rationale
Option B (TFE3 or TFEB gene translocation)
Renal cell carcinoma is uncommon in children but becomes the most frequent renal malignancy during the second decade of life. The commonest pediatric subtype is translocation-associated RCC, usually involving TFE3 on chromosome Xp11.2 or TFEB on chromosome 6p21. These rearrangements define a biologically distinct tumor group from conventional adult RCC. Children may present with hematuria, flank pain, or a palpable mass, and localized disease is usually treated with nephrectomy alone because chemotherapy and radiotherapy have limited activity.
A biopsy from a rapidly enlarging childhood soft-tissue mass shows a monotonous population of small, round, blue cells. All of the following are included among the important differential diagnoses except:
---
- (A) Rhabdomyosarcoma
- (B) Neuroblastoma
- (C) Desmoplastic small round cell tumor
- (D) Non-Hodgkin lymphoma
💡 Click to Reveal Answer & Nelson Rationale
Option C (Desmoplastic small round cell tumor)
The classic group of childhood small, round, blue cell tumors includes rhabdomyosarcoma, neuroblastoma, Ewing sarcoma, and non-Hodgkin lymphoma. These tumors share a similar appearance on routine light microscopy and require immunohistochemistry and molecular testing for definitive classification. Rhabdomyosarcoma shows skeletal muscle differentiation with desmin and myogenin positivity, neuroblastoma may show neuropil and Homer Wright rosettes, and non-Hodgkin lymphoma is identified by lymphoid lineage markers. Desmoplastic small round cell tumor is also a small round cell neoplasm, but it is not part of the specific classic differential group listed in this Nelson context.
A 3-year-old girl presents with intermittent vaginal bleeding and a painless mass protruding through the vaginal introitus. Examination reveals a polypoidal, grapelike lesion. Which diagnosis is most likely?
---
- (A) Embryonal rhabdomyosarcoma, botryoid variant
- (B) Alveolar rhabdomyosarcoma
- (C) Clear cell sarcoma of the vagina
- (D) Vaginal germ cell tumor
💡 Click to Reveal Answer & Nelson Rationale
Option A (Embryonal rhabdomyosarcoma, botryoid variant)
A grapelike mass protruding through the vaginal opening in a young child is characteristic of sarcoma botryoides, a botryoid variant of embryonal rhabdomyosarcoma. It arises beneath the mucosal surface of hollow organs such as the vagina, bladder, or biliary tract and forms polypoidal clusters that resemble a bunch of grapes. Vaginal rhabdomyosarcoma may also cause bleeding, urinary obstruction, rectal symptoms, or recurrent urinary tract complaints. Recognizing this classic presentation is important because the lesion can initially be mistaken for a benign polyp.
A 16-year-old adolescent presents with a slowly enlarging painless mass over the posterior distal femur. Imaging shows a well-differentiated surface osteogenic tumor without medullary cavity invasion. Which statement is most accurate?
---
- (A) It is a parosteal osteosarcoma and may be cured with complete surgical resection alone
- (B) It is a periosteal osteosarcoma and has the lowest metastatic potential among osteosarcomas
- (C) It is a conventional high-grade osteosarcoma and requires chemotherapy despite absent medullary invasion
- (D) It is a telangiectatic osteosarcoma and is commonly confused with an aneurysmal bone cyst because of surface ossification
💡 Click to Reveal Answer & Nelson Rationale
Option A (It is a parosteal osteosarcoma and may be cured with complete surgical resection alone)
The tumor is most consistent with parosteal osteosarcoma, a low-grade, well-differentiated surface osteosarcoma that most commonly arises from the posterior aspect of the distal femur. Unlike conventional high-grade osteosarcoma, it usually does not invade the medullary cavity and has a low tendency for metastatic spread. Therefore, complete surgical resection alone is often curative. Distinguishing this subtype is important because unnecessary intensive chemotherapy can be avoided in adequately resected low-grade disease.
All of the following are recognized pathologic subtypes of conventional high-grade osteosarcoma except:
---
- (A) Osteoblastic
- (B) Chondroblastic
- (C) Telangiectatic
- (D) Parosteal
💡 Click to Reveal Answer & Nelson Rationale
Option D (Parosteal)
The four recognized pathologic subtypes of conventional high-grade osteosarcoma are osteoblastic, fibroblastic, chondroblastic, and telangiectatic. These are classified according to the predominant histologic pattern and matrix produced by the malignant cells. Parosteal osteosarcoma is not a conventional high-grade subtype; it is a distinct, usually low-grade surface osteosarcoma that most often arises from the posterior aspect of the distal femur and generally has a much more favorable prognosis.
A 15-year-old adolescent with nonmetastatic Ewing sarcoma of the pelvis receives vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide before definitive local control. Which treatment modification is most likely to improve outcome without changing the individual drug doses?
---
- (A) Administer chemotherapy every 14 days instead of every 21 days
- (B) Use definitive radiotherapy for local control because Ewing sarcoma is radiosensitive
- (C) Add myeloablative chemotherapy with stem cell rescue
- (D) Resume postoperative chemotherapy only after complete surgical recovery
💡 Click to Reveal Answer & Nelson Rationale
Option A (Administer chemotherapy every 14 days instead of every 21 days)
Nonmetastatic Ewing sarcoma is treated with multiagent chemotherapy combined with local control by surgery, radiotherapy, or both. The standard chemotherapy backbone includes vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide. Administering the same regimen every 14 days rather than every 21 days improves outcome by reducing the interval available for regrowth of residual tumor cells without increasing individual drug doses. Chemotherapy is usually given before local control because it treats micrometastatic disease, rapidly reduces the soft-tissue component, relieves pain, and may facilitate complete resection.
A 12-year-old boy is noted to have a painless, hard swelling near the distal femur. Radiography shows a metaphyseal bony projection directed away from the adjacent joint, with continuity of both cortex and medullary cavity with the parent bone. Which diagnosis is most likely?
---
- (A) Osteochondroma
- (B) Parosteal osteosarcoma
- (C) Periosteal chondroma
- (D) Subperiosteal osteoblastoma
💡 Click to Reveal Answer & Nelson Rationale
Option A (Osteochondroma)
The described lesion is classic for an osteochondroma, one of the most common benign bone tumors in children. It arises from the metaphysis of a long bone, especially the distal femur, proximal tibia, or proximal humerus. Radiographically, it appears as a sessile or pedunculated bony projection that points away from the nearby joint.
The most important diagnostic feature is continuity of both the cortex and medullary cavity of the lesion with the parent bone. The palpable mass may seem larger than it appears on radiography because the cartilage cap is not well visualized on plain films. Most lesions are asymptomatic and require observation only. Excision is reserved for pain, nerve compression, functional impairment, deformity, or concern for malignant transformation.
A 13-year-old child has multiple enchondromas involving the hands and long bones, associated with limb-length inequality and progressive skeletal deformity. Examination also reveals multiple soft-tissue vascular lesions. Which of the following is the most likely diagnosis?
---
- (A) Ollier disease
- (B) Maffucci syndrome
- (C) Multiple hereditary exostoses
- (D) Fibrous dysplasia with McCune-Albright syndrome
💡 Click to Reveal Answer & Nelson Rationale
Option B (Maffucci syndrome)
Multiple enchondromas associated with soft-tissue angiomas define Maffucci syndrome. Enchondromas are benign hyaline cartilage tumors that arise centrally within the medullary canal and commonly involve the small bones of the hands. Multifocal disease can produce skeletal dysplasia, limb-length inequality, joint deformity, and short stature. The presence of vascular malformations is the key feature that distinguishes Maffucci syndrome from Ollier disease. Both conditions have an increased risk of malignant transformation, particularly to chondrosarcoma, so long-term surveillance is important.
A 4-month-old infant with a germline RB1 pathogenic variant has bilateral retinoblastoma. Both eyes contain large intraocular tumors, but useful vision may still be preserved. Because of the child’s young age, intraarterial chemotherapy is considered to carry a higher risk of complications. Which treatment approach is most appropriate?
---
- (A) Enucleation of the more affected eye with focal therapy to the contralateral eye
- (B) Ophthalmic artery chemotherapy with adjunctive intravitreal and focal therapy
- (C) Systemic carboplatin, vincristine, and etoposide with focal ocular therapy
- (D) Episcleral plaque radiotherapy with systemic chemoreduction and focal therapy
💡 Click to Reveal Answer & Nelson Rationale
Option C (Systemic carboplatin, vincristine, and etoposide with focal ocular therapy)
In a very young infant with bilateral retinoblastoma, the major goals are cure, preservation of useful vision, retention of the eyes whenever feasible, and reduction of long-term treatment toxicity. Large bilateral intraocular tumors are commonly managed with systemic chemoreduction using carboplatin, vincristine, and etoposide, followed by focal therapy such as laser photocoagulation or cryotherapy. Systemic chemotherapy reduces tumor size and permits focal treatment of residual disease. It is especially appropriate in very young infants in whom ophthalmic artery chemotherapy may carry a higher procedural risk. Enucleation is reserved for eyes in which useful vision cannot be preserved or for tumors that remain unresponsive or recur despite conservative treatment.
A 14-year-old boy presents with a rapidly enlarging testicular mass. Serum tumor markers show markedly elevated AFP with normal β-hCG and LDH. Histopathology confirms a pure germ cell tumor. Based on the clinical and tumor marker profile, which of the following is the most likely diagnosis?
---
- (A) Seminoma
- (B) Embryonal carcinoma
- (C) Yolk sac tumor
- (D) Choriocarcinoma
💡 Click to Reveal Answer & Nelson Rationale
Option C (Yolk sac tumor)
Yolk sac tumor (endodermal sinus tumor) is the most common malignant germ cell tumor in children and is characteristically associated with elevated AFP. In boys, most pediatric testicular germ cell tumors are pure yolk sac tumors, and approximately 85% present as stage I disease. AFP is produced by yolk sac elements and serves as an important diagnostic, prognostic, and surveillance marker. In contrast, β-hCG is typically not elevated in pure yolk sac tumors. Recognition of the characteristic tumor marker pattern is essential because germ cell tumor classification increasingly relies on clinicopathologic and biochemical correlation.
**Table:** Clinical Features of Germ Cell Tumors
![[7c7c1a68_medium_table__12__1784358439.png]]
A 15-year-old boy presents with a rapidly enlarging testicular mass. Serum tumor markers reveal markedly elevated AFP, elevated β-hCG, and mildly elevated LDH. Histopathology confirms a pure germ cell tumor without mixed elements. Which of the following tumor types is most consistent with this tumor marker profile?
---
- (A) Yolk sac tumor
- (B) Choriocarcinoma
- (C) Embryonal carcinoma
- (D) Immature teratoma
💡 Click to Reveal Answer & Nelson Rationale
Option C (Embryonal carcinoma)
Embryonal carcinoma is the only germ cell tumor in the provided marker profile that characteristically elevates both AFP and β-hCG. AFP reflects yolk sac differentiation, whereas β-hCG is produced by syncytiotrophoblastic elements. Embryonal carcinoma is biologically aggressive and often demonstrates pluripotent differentiation, explaining its ability to produce both markers. LDH may also be elevated but is nonspecific. Recognition of combined AFP and β-hCG elevation is a high-yield method of distinguishing embryonal carcinoma from other pediatric germ cell tumors.
**Table:** Serum Tumor Marker Levels for Pediatric GCTs
![[5248e0f3_small_table__4__1784358588.png]]
A 12-year-old boy is found to have hepatocellular carcinoma in a noncirrhotic liver. His history includes poor metabolic control, multiple hepatic adenomas, and progressive hepatomegaly. Which underlying disorder most likely predisposed him to this malignancy?
---
- (A) Alpha-1 antitrypsin deficiency
- (B) Progressive familial intrahepatic cholestasis
- (C) Glycogen storage disease type I
- (D) Alagille syndrome
💡 Click to Reveal Answer & Nelson Rationale
Option C (Glycogen storage disease type I)
Glycogen storage disease type I predisposes to hepatocellular carcinoma in a noncirrhotic liver, particularly in patients with poor long-term metabolic control. Persistent metabolic derangement promotes marked hepatomegaly and the development of multiple hepatic adenomas, some of which may undergo malignant transformation. The combination of a noncirrhotic liver, multiple adenomas, and poor metabolic control is therefore highly suggestive of glycogen storage disease type I as the underlying predisposing condition.
![[8acf091a_1784285399276_1784285400.png]]
A 4-year-old child presents with recurrent painful skull swelling and a lytic calvarial lesion on imaging. Biopsy demonstrates lesional cells that are CD1a-positive and CD207 (langerin)-positive. Molecular testing is performed to evaluate the pathogenesis of the disorder. Which of the following genetic abnormalities is most commonly associated with this disease?
---
- (A) Germline PRF1 mutation causing uncontrolled macrophage activation
- (B) Somatic BRAF V600E mutation involving the MAPK signaling pathway
- (C) TFE3 translocation resulting in aberrant transcription factor activation
- (D) EWSR1-WT1 translocation producing a chimeric oncogenic protein
💡 Click to Reveal Answer & Nelson Rationale
Option B (Somatic BRAF V600E mutation involving the MAPK signaling pathway)
The child has Langerhans cell histiocytosis (LCH), characterized by lesional cells expressing CD1a and CD207 (langerin). Current understanding indicates that LCH is a clonal myeloid neoplasm driven by constitutive activation of the MAPK signaling pathway. The most common molecular abnormality is the somatic BRAF V600E mutation, which is identified in a substantial proportion of patients. In patients lacking BRAF V600E, other activating mutations involving MAP2K1, ARAF, and related MAPK pathway genes may be found. Recognition of MAPK pathway activation has transformed the conceptual understanding of LCH from a purely inflammatory disorder to a clonal neoplastic process and has led to the development of targeted therapies.
A 6-year-old child with biopsy-confirmed Langerhans cell histiocytosis has fever, hepatosplenomegaly, cytopenias, and multifocal skeletal lesions. Molecular testing demonstrates a BRAF V600E pathogenic variant. Which of the following is the most appropriate initial systemic treatment?
---
- (A) Vinblastine combined with corticosteroids
- (B) Cytarabine monotherapy followed by a BRAF inhibitor
- (C) Cladribine combined with cytarabine
- (D) Vemurafenib combined with corticosteroids
💡 Click to Reveal Answer & Nelson Rationale
Option A (Vinblastine combined with corticosteroids)
This child has multisystem Langerhans cell histiocytosis with risk-organ involvement, suggested by hepatosplenomegaly and cytopenias. The standard first-line systemic treatment for childhood multifocal or disseminated Langerhans cell histiocytosis is vinblastine combined with corticosteroids. The presence of a BRAF V600E pathogenic variant confirms MAPK pathway activation and has therapeutic relevance, but it does not automatically replace standard first-line treatment. BRAF or MEK inhibitors are generally considered in refractory, relapsed, or selected high-risk disease when conventional therapy is inadequate. Early recognition of risk-organ involvement is important because it is associated with a higher risk of treatment failure and mortality.
**Table: **Clinical Features, Investigations, and Treatment of Langerhans Cell Histiocytosis, Erdheim-Chester Disease, and Rosai-Dorfman-Destombes Disease
![[7c6525c4_medium_table__13__1784358724.png]]
A 13-year-old child presents with persistent bilateral lower-limb pain, fatigue, low-grade fever, and progressive polyuria. Examination reveals xanthelasma and mild exophthalmos. Whole-body 18F-FDG PET and CT demonstrate symmetric involvement of the long bones, perinephric soft-tissue infiltration, and circumferential periaortic sheathing. Which of the following is the most likely diagnosis?
---
- (A) Erdheim-Chester disease
- (B) Rosai-Dorfman-Destombes disease
- (C) Multisystem Langerhans cell histiocytosis
- (D) Juvenile xanthogranuloma
💡 Click to Reveal Answer & Nelson Rationale
Option A (Erdheim-Chester disease)
Erdheim-Chester disease is a non-Langerhans cell histiocytosis characterized by symmetric involvement of the long bones, particularly of the lower limbs, together with multisystem infiltration. Lower-limb pain, xanthelasma, diabetes insipidus, exophthalmos, perinephric infiltration, and cardiovascular involvement are characteristic manifestations. Perinephric soft-tissue infiltration produces the classic “hairy kidney” appearance, while circumferential periaortic infiltration produces a “coated aorta.” Whole-body 18F-FDG PET, CT of the chest, abdomen, and pelvis, brain MRI, and cardiac MRI are important for defining disease extent. BRAF or MEK inhibitors are particularly relevant in severe or life-threatening disease involving the heart or central nervous system.
A 6-year-old child presents with fever, pallor, bone pains and bleeding gums. The peripheral blood smear is shown below. It reveals a large population of uniform, round to oval cells with high nuclear-cytoplasmic ratio, finely dispersed chromatin, and inconspicuous nucleoli. Which of the following is the most likely diagnosis?
---
- (A) Acute Myeloid Leukemia (AML)
- (B) Chronic Myeloid Leukemia (CML) – Blast crisis
- (C) B-cell Acute Lymphoblastic Leukemia (B-ALL)
- (D) Juvenile Myelomonocytic Leukemia (JMML)
💡 Click to Reveal Answer & Nelson Rationale
Option C (B-cell Acute Lymphoblastic Leukemia (B-ALL))
Bone marrow aspirate showing blasts in this case of B-cell acute lymphoblastic leukemia. The arrow shows a mitotic figure (May-Grünwald-Giemsa stain). Wright-Giemsa-stained bone marrow aspirates and Hematoxylin and eosin (H&E)-stained biopsies are evaluated for morphology to help distinguish lymphoblasts from myeloblasts. Lymphoblasts are characterized by – high nucleus-to-cytoplasm rati, inconspicuous nucleoli, scant cytoplasm, fine and immature chromatin and , smaller size cells. French-American-British (FAB) Cooperative Working Group was applied for morphologic classification of ALL. The FAB system defines three categories of lymphoblasts. L1 lymphoblasts are smaller, with scant cytoplasm and inconspicuous nucleoli. Cells of the L2 variety are larger and demonstrate considerable heterogeneity in size, prominent nucleoli, and more abundant cytoplasm. Lymphoblasts of the L3 type, notable for their deep cytoplasmic basophilia, are large, frequently display prominent cytoplasmic vacuolation, and are morphologically identical to Burkitt lymphoma cells.
A bone marrow aspirate image as shown in below image shows blasts with slender, needle-shaped Auer rods arranged in bundles ("faggot cells"). What is the most likely subtype of AML?
---
- (A) AML-M0 (minimally differentiated)
- (B) Acute promyelocytic leukemia (APL, M3)
- (C) AML-M5 (monocytic)
- (D) ALL
💡 Click to Reveal Answer & Nelson Rationale
Option B (Acute promyelocytic leukemia (APL, M3))
The presence of "faggot cells," blasts containing bundles of Auer rods, is pathognomonic for APL. This morphological finding is important because it prompts immediate initiation of ATRA therapy even before genetic confirmation to prevent fatal coagulopathy.
A karyotype shows inv(16)(p13q22).
Which AML subtype is most likely associated with this finding?
![[2430c4f3_1757931747037_1757931747.png]]
---
- (A) AML-M4Eo (myelomonocytic with eosinophilia)
- (B) AML-M2 (with maturation)
- (C) AML-M6 (erythroleukemia)
- (D) AML-M7 (megakaryoblastic)
💡 Click to Reveal Answer & Nelson Rationale
Option A (AML-M4Eo (myelomonocytic with eosinophilia))
inv(16) is strongly associated with AML-M4Eo, a subtype with myelomonocytic morphology and abnormal eosinophils in the marrow. It is considered a favorable prognostic abnormality, and recognizing it guides treatment intensity and prognosis.
A karyotype shows inv(16)(p13q22).
Which AML subtype is most likely associated with this finding?
![[2430c4f3_1757931747037_1757931747.png]]
---
- (A) AML-M4Eo (myelomonocytic with eosinophilia)
- (B) AML-M2 (with maturation)
- (C) AML-M6 (erythroleukemia)
- (D) AML-M7 (megakaryoblastic)
💡 Click to Reveal Answer & Nelson Rationale
Option A (AML-M4Eo (myelomonocytic with eosinophilia))
inv(16) is strongly associated with AML-M4Eo, a subtype with myelomonocytic morphology and abnormal eosinophils in the marrow. It is considered a favorable prognostic abnormality, and recognizing it guides treatment intensity and prognosis.
Peripheral smear shows marked leukocytosis with all stages of granulocytic maturation: myelocytes, metamyelocytes, band forms, and mature neutrophils. Blasts are less than 5%. Basophils are increased. What is the most likely diagnosis?
---
- (A) Acute lymphoblastic leukemia
- (B) Chronic myeloid leukemia (CML)
- (C) Polycythemia vera
- (D) Juvenile myelomonocytic leukemia (JMML)
💡 Click to Reveal Answer & Nelson Rationale
Option B (Chronic myeloid leukemia (CML))
The hallmark of CML smear is the “myelocyte bulge,” meaning a full spectrum of granulocytic precursors. Increased basophils and eosinophils are also characteristic. Blasts are typically low in chronic phase.
Which targeted therapy is most appropriate?
---
- (A) Cytarabine
- (B) Methotrexate
- (C) Imatinib
- (D) Vincristine
💡 Click to Reveal Answer & Nelson Rationale
Option C (Imatinib)
The Philadelphia chromosome produces the BCR-ABL1 tyrosine kinase fusion protein, which is specifically targeted by imatinib and other TKIs. This revolutionized CML treatment, improving survival dramatically in children and adults.
What are these hallmark cells?
---
- (A) Reed–Sternberg cells
- (B) Langerhans cells
- (C) Myeloblasts
- (D) Plasma cells
💡 Click to Reveal Answer & Nelson Rationale
Option A (Reed–Sternberg cells)
Reed–Sternberg cells are diagnostic of Hodgkin lymphoma. They are large binucleated cells with prominent nucleoli, classically described as “owl’s eye” appearance. They arise from B-cell lineage.
What is the most likely diagnosis?
---
- (A) Burkitt lymphoma
- (B) Diffuse large B-cell lymphoma
- (C) T-cell lymphoblastic lymphoma
- (D) Anaplastic large cell lymphoma
💡 Click to Reveal Answer & Nelson Rationale
Option A (Burkitt lymphoma)
The “starry sky” appearance is pathognomonic for Burkitt lymphoma, produced by rapidly proliferating lymphoid cells with scattered tingible-body macrophages. This histologic feature is a diagnostic hallmark.
What is the most likely diagnosis?
---
- (A) Neuroblastoma
- (B) Ewing sarcoma
- (C) Retinoblastoma
- (D) Meningioma
💡 Click to Reveal Answer & Nelson Rationale
Option A (Neuroblastoma)
Homer Wright rosettes, composed of tumor cells arranged around a central fibrillary core, are characteristic of neuroblastoma. They reflect primitive neuroectodermal differentiation.
What is the most likely diagnosis?
---
- (A) Retinoblastoma
- (B) Coats disease
- (C) Retinal astrocytoma
- (D) Persistent hyperplastic primary vitreous (PHPV)
💡 Click to Reveal Answer & Nelson Rationale
Option A (Retinoblastoma)
Retinoblastoma classically appears as a cream-colored intraocular retinal mass with prominent feeder vessels. On imaging (ultrasound/CT), intraocular calcification is characteristic and virtually diagnostic.
CT scan of abdomen showing a large, well-circumscribed mass in the right hepatic lobe, compressing but not invading adjacent structures. What is the most likely tumor seen in this CT image of a 2-year-old child with elevated AFP?
---
- (A) Hepatoblastoma
- (B) Mesenchymal hamartoma
- (C) Metastatic neuroblastoma
- (D) Focal nodular hyperplasia
💡 Click to Reveal Answer & Nelson Rationale
Option A (Hepatoblastoma)
Hepatoblastoma appears on CT as a large, well-defined hepatic mass, often with heterogeneous enhancement and calcifications. Clinical correlation with elevated AFP in a young child strongly supports this diagnosis.
A 5-year-old boy presents with persistent scalp swelling and intermittent bone pain for 3 months. Skeletal survey demonstrates a solitary lytic lesion involving the skull. Biopsy of the lesion is shown in the image.
Which of the following immunohistochemical profiles is most characteristic and diagnostic of the underlying disorder?
---
- (A) CD68 and CD163 positivity with absent CD1a expression
- (B) CD1a and CD207 positivity with variable S100 expression
- (C) S100 and CD68 positivity with absent CD207 expression
- (D) CD30 and ALK positivity with focal CD1a expression
💡 Click to Reveal Answer & Nelson Rationale
Option B (CD1a and CD207 positivity with variable S100 expression)
The clinical scenario and histopathology are characteristic of Langerhans cell histiocytosis (LCH), a clonal dendritic cell neoplasm that commonly presents with lytic skull lesions in children. The diagnosis is established by demonstrating expression of CD1a and CD207 (langerin) in lesional cells. CD207 is particularly important because it correlates with the presence of Birbeck granules and is considered highly specific for Langerhans cells. Although S100 may also be positive, it lacks specificity and is not sufficient for diagnosis. Therefore, the combination of CD1a and CD207 expression remains the diagnostic immunophenotypic hallmark of LCH.
![[28742918_1784285905529_1784285910.png]]
The above high-power histopathologic image is obtained from a lymph node biopsy of a 15-year-old child with persistent painless cervical lymphadenopathy. Which cell is demonstrated in the image?
---
- (A) Lacunar cell of nodular sclerosis Hodgkin lymphoma
- (B) Lymphocyte-predominant cell of nodular lymphocyte-predominant Hodgkin lymphoma
- (C) Classic Reed-Sternberg cell
- (D) Hallmark cell of anaplastic large cell lymphoma
💡 Click to Reveal Answer & Nelson Rationale
Option C (Classic Reed-Sternberg cell)
The image demonstrates the pathognomonic malignant cell of classical Hodgkin lymphoma. A classic Reed-Sternberg cell is a large cell with abundant cytoplasm and two or more nuclei or nuclear lobes containing prominent eosinophilic nucleoli. The nuclei commonly produce the characteristic mirror-image appearance. Reed-Sternberg cells arise clonally from germinal-center B cells but lose most normal B-cell gene expression and function. Similar-appearing cells may occasionally occur in infectious mononucleosis and non-Hodgkin lymphoma, so diagnosis requires interpretation within the appropriate histologic and immunophenotypic background.
A lymph node biopsy from an adolescent with Hodgkin lymphoma demonstrates neoplastic L and H (“popcorn”) cells. Which of the following World Health Organization subtypes is most likely?
---
- (A) Lymphocyte-rich classical Hodgkin lymphoma
- (B) Nodular sclerosis classical Hodgkin lymphoma
- (C) Mixed cellularity classical Hodgkin lymphoma
- (D) Nodular lymphocyte-predominant Hodgkin lymphoma
💡 Click to Reveal Answer & Nelson Rationale
Option D (Nodular lymphocyte-predominant Hodgkin lymphoma)
The image demonstrates nodular lymphocyte-predominant Hodgkin lymphoma, characterized by a nodular lymphoid proliferation containing neoplastic lymphocyte-predominant cells. These cells are historically termed L and H cells and are also called popcorn cells because of their folded, multilobulated nuclei. This subtype is biologically and immunophenotypically distinct from classical Hodgkin lymphoma, which contains classic Reed-Sternberg cells or their variants.
The above images demonstrate CD68 immunostaining in lymph node biopsies from two patients with Hodgkin lymphoma. Which of the following statements is most accurate regarding the patient represented by the image with greater CD68-positive staining?
---
- (A) More likely to have a favorable response to therapy
- (B) More likely to have treatment failure and an unfavorable prognosis
- (C) More likely to have nodular lymphocyte-predominant Hodgkin lymphoma
- (D) More likely to have Epstein-Barr virus–negative disease
💡 Click to Reveal Answer & Nelson Rationale
Option B (More likely to have treatment failure and an unfavorable prognosis)
The left image shows only a few CD68-positive macrophages within the tumor microenvironment and is associated with successful treatment. The right image shows numerous CD68-positive macrophages and is associated with treatment failure. In Hodgkin lymphoma, abundant tumor-associated macrophages support Reed-Sternberg cell survival through cytokine signaling and immune-regulatory interactions. Therefore, increased CD68-positive macrophage infiltration is an adverse prognostic marker, whereas sparse macrophage infiltration is associated with a more favorable treatment response.
![[4175ffd3_1784286338471_1784286340.png]]
The PET-CT image shown above was obtained after two cycles of chemotherapy in a child with Hodgkin lymphoma. According to the Deauville 5-point scoring system, which finding would correspond to a Deauville score of 4?
---
- (A) No abnormal FDG uptake within previously involved sites
- (B) FDG uptake greater than mediastinal blood pool but lower than or equal to the liver
- (C) FDG uptake moderately higher than the liver at any site
- (D) Markedly increased FDG uptake compared with the liver or appearance of new lesions
💡 Click to Reveal Answer & Nelson Rationale
Option C (FDG uptake moderately higher than the liver at any site)
The Deauville 5-point scale is the standard method for response assessment in FDG-avid lymphomas such as Hodgkin lymphoma. It compares residual lesion uptake with physiologic uptake in the mediastinum and liver. A score of 4 indicates residual metabolic activity that is moderately greater than liver uptake. This finding suggests residual active disease but is distinct from a score of 5, which requires markedly increased uptake relative to the liver or the appearance of new FDG-avid lesions. The PET-CT shown demonstrates the type of imaging used for interim response assessment, which has become central to risk-adapted therapy in Hodgkin lymphoma.
![[8e90ed17_1784286489060_1784286537.png]]
![[8cb0a01f_1784286553103_1784286554.png]]
The immunohistochemical stains shown above demonstrate strong CD30 expression in one tumor and strong CD20 expression in another. Which of the following pairings is most appropriate?
---
- (A) CD30 – Anaplastic large cell lymphoma; CD20 – Burkitt lymphoma
- (B) CD30 – Burkitt lymphoma; CD20 – Anaplastic large cell lymphoma
- (C) CD30 – Lymphoblastic lymphoma; CD20 – Diffuse large B-cell lymphoma
- (D) CD30 – Diffuse large B-cell lymphoma; CD20 – Lymphoblastic lymphoma
💡 Click to Reveal Answer & Nelson Rationale
Option A (CD30 – Anaplastic large cell lymphoma; CD20 – Burkitt lymphoma)
The left image demonstrates strong CD30 expression, which is characteristic of anaplastic large cell lymphoma. CD30 is a hallmark surface marker of ALCL and also serves as the therapeutic target for brentuximab vedotin. The right image demonstrates strong CD20 expression in Burkitt lymphoma. Burkitt lymphoma is a mature B-cell neoplasm and commonly expresses CD20 along with other mature B-cell markers. In this figure, the stains specifically represent CD30-positive ALCL and CD20-positive Burkitt lymphoma.
The high-power histopathologic image shown above is most consistent with which subtype of childhood non-Hodgkin lymphoma?
---
- (A) Burkitt lymphoma
- (B) Diffuse large B-cell lymphoma
- (C) Lymphoblastic lymphoma
- (D) Anaplastic large cell lymphoma
💡 Click to Reveal Answer & Nelson Rationale
Option B (Diffuse large B-cell lymphoma)
The image demonstrates large atypical lymphoid cells with abundant cytoplasm, vesicular nuclei, and prominent nucleoli, characteristic of diffuse large B-cell lymphoma (DLBCL). In the Nelson figure, this morphology corresponds to panel B. DLBCL is a mature B-cell lymphoma and represents one of the major pediatric non-Hodgkin lymphoma subtypes. It shares expression of mature B-cell markers such as CD20 and CD22 and is biologically distinct from Burkitt lymphoma, lymphoblastic lymphoma, and anaplastic large cell lymphoma. Recognition of morphology remains an important examination skill because treatment protocols differ substantially among these entities.
![[92635ca6_1784286824274_1784286825.png]]
A 10-year-old boy presents with early-onset puberty and recurrent headaches. MRI of the brain was done as shown. Which of the following investigations would be most useful in supporting the diagnosis?
---
- (A) Serum and CSF β-hCG with α-fetoprotein
- (B) Serum β-hCG with placental alkaline phosphatase
- (C) Serum α-fetoprotein with neuron-specific enolase
- (D) CSF β-hCG with serum carcinoembryonic antigen
💡 Click to Reveal Answer & Nelson Rationale
Option A (Serum and CSF β-hCG with α-fetoprotein)
The MRI shows a well-defined enhancing mass in the pineal region with associated ventricular enlargement, indicating obstructive hydrocephalus. In a boy with precocious puberty, this strongly suggests an intracranial germ cell tumor, particularly a β-hCG–secreting tumor. Serum and CSF β-hCG help identify germinomatous or choriocarcinomatous components, while α-fetoprotein elevation suggests yolk sac or other nongerminomatous elements. These markers aid diagnosis, tumor classification, treatment planning, and follow-up.
![[d73d2f8f_1784286964743_1784286966.png]]
A 4-year-old child presents with progressive headache, vomiting, and gait instability. MRI of the brain was performed as shown. Based on the radiologic appearance, which of the following statements regarding this tumor is most accurate?
---
- (A) The tumor is most commonly associated with leptomeningeal dissemination at diagnosis and requires craniospinal irradiation in most patients.
- (B) The lesion is classified as a WHO grade II tumor and commonly arises from the floor of the fourth ventricle.
- (C) Complete surgical excision alone may achieve long-term survival approaching 80–100% in the typical histologic subtype.
- (D) The lesion is characterized by diffuse pontine infiltration and carries a mortality exceeding 90%.
💡 Click to Reveal Answer & Nelson Rationale
Option C (Complete surgical excision alone may achieve long-term survival approaching 80–100% in the typical histologic subtype.)
The MRI shows a well-circumscribed cystic mass arising in the cerebellar hemisphere with an enhancing solid mural nodule. This radiologic pattern is highly characteristic of cerebellar pilocytic astrocytoma, a WHO grade I low-grade glioma commonly encountered in young children. The large cystic component produces local mass effect and may obstruct cerebrospinal fluid pathways, explaining the child’s headache, vomiting, and gait instability. The enhancing mural nodule represents the viable neoplastic component, whereas the cyst itself may contain tumor-associated fluid.
Pilocytic astrocytoma usually grows slowly and remains localized. Its circumscribed nature often permits gross total surgical resection, particularly when the tumor is situated within a cerebellar hemisphere. Complete excision is frequently curative, with survival approaching 80–100% in totally resected lesions. Adjuvant chemotherapy or radiotherapy is generally unnecessary after complete resection. Residual or unresectable tumors may require observation, repeat surgery, or systemic therapy depending on progression, symptoms, location, and molecular characteristics.
The lesion should be differentiated from other posterior fossa tumors. Medulloblastoma is usually a more solid, densely cellular midline tumor with a marked tendency for cerebrospinal fluid dissemination. Ependymoma typically arises from the fourth ventricle and may extend through the foramina toward the cerebellopontine angles. Diffuse intrinsic pontine glioma causes infiltrative expansion of the pons rather than a sharply demarcated cystic cerebellar mass. Therefore, both the imaging morphology and favorable surgical prognosis support pilocytic astrocytoma.
![[5e107a58_1784287087088_1784287088.png]]
A 14-year-old adolescent presents with progressive left-sided weakness and headache. MRI of the brain was done as shown. Which is the most likely diagnosis?
---
- (A) Pilocytic astrocytoma
- (B) High-grade astrocytoma
- (C) Ependymoma
- (D) Medulloblastoma
💡 Click to Reveal Answer & Nelson Rationale
Option B (High-grade astrocytoma)
The MRI shows an infiltrative intra-axial mass centered in the thalamus, with surrounding edema and mass effect. A thalamic lesion can interrupt corticospinal and sensory pathways, explaining the contralateral weakness and sensory symptoms. In an adolescent, this radiologic pattern is most consistent with a high-grade thalamic astrocytoma.
High-grade pediatric astrocytomas are aggressive infiltrative tumors with marked cellular atypia, mitotic activity, and variable necrosis or microvascular proliferation. Thalamic and other midline high-grade gliomas may be associated with histone H3 abnormalities and often behave more aggressively than circumscribed low-grade gliomas. Their deep location limits the feasibility of complete surgical excision, and treatment generally requires biopsy or maximal safe resection followed by radiotherapy and systemic therapy.
The image does not show the well-circumscribed cystic lesion with an enhancing mural nodule typical of pilocytic astrocytoma. It is also not centered in the fourth ventricle, as expected in ependymoma, and it is not a posterior fossa midline mass, as usually seen in medulloblastoma.
![[e87be5cd_1784287210133_1784287210.png]]
A child with an abdominal mass undergoes bone marrow aspiration, and the histopathologic image is shown. Which morphologic finding most strongly supports the diagnosis?
---
- (A) Neuroblasts arranged around central neuropil without a true lumen
- (B) Neuroblasts arranged around a central vascular channel with an anuclear zone
- (C) Tumor cells forming a true rosette around an empty central lumen
- (D) Small round cells surrounding central necrosis without fibrillary material
💡 Click to Reveal Answer & Nelson Rationale
Option A (Neuroblasts arranged around central neuropil without a true lumen)
The bone marrow aspirate demonstrates metastatic neuroblastoma with clusters of small round blue cells showing Homer Wright rosette formation. In a Homer Wright rosette, neuroblasts are arranged around a central core of eosinophilic fibrillary neuropil without a true lumen. The fibrillary material represents neuritic processes and indicates neuroblastic differentiation. Such rosettes may occur in neuroblastoma and other primitive neuroectodermal tumors, but in a child with an abdominal mass and marrow involvement, they strongly support neuroblastoma. Marrow metastasis is also important for staging and risk stratification because it may place the child in metastatic disease categories depending on age and extent of involvement.
![[4cadbd99_1784287341017_1784287342.png]]
A 3-year-old child presents with an abdominal mass and the ocular finding shown in the image. Which combination can confirm the suspected diagnosis without biopsy of the primary tumor?
---
- (A) Bone marrow showing small round blue tumor cells with elevated urinary VMA or HVA
- (B) Gallium-68 DOTATATE-avid skeletal lesions with elevated urinary VMA or HVA
- (C) Iodine-123 MIBG-avid adrenal mass with elevated urinary VMA or HVA
- (D) Bone marrow showing small round blue tumor cells with elevated serum neuron-specific enolase
💡 Click to Reveal Answer & Nelson Rationale
Option A (Bone marrow showing small round blue tumor cells with elevated urinary VMA or HVA)
The image shows periorbital ecchymosis with proptosis, a classic sign of orbital metastasis from neuroblastoma. Neuroblastoma is usually confirmed by histopathologic examination of tissue obtained from the primary tumor. However, biopsy of the primary tumor is not essential when two findings are present together: characteristic small round blue tumor cells in bone marrow and elevated urinary catecholamine metabolites, namely vanillylmandelic acid or homovanillic acid. Bone marrow examination provides direct pathologic evidence of metastatic neuroblastic tumor, while elevated urinary VMA or HVA provides biochemical evidence of catecholamine production by the tumor. These metabolites are elevated in approximately 95% of patients and are therefore highly useful for diagnosis and follow-up.
Functional imaging is important but serves a different purpose. Iodine-123 MIBG scintigraphy is the preferred study for defining the extent of neuroblastoma because most neuroblastoma cells take up catecholamine analogues. It detects the primary tumor as well as osseous and soft-tissue metastases. Gallium-68 DOTATATE PET imaging may be useful in selected centers, particularly when the MIBG scan is negative, because some neuroblastomas express somatostatin receptors. However, neither MIBG nor DOTATATE imaging alone provides histologic confirmation. Therefore, imaging plus elevated catecholamine metabolites is strongly supportive but does not replace the accepted combination of marrow tumor cells and elevated urinary VMA or HVA when primary tumor biopsy is omitted.
A 3-year-old child undergoes contrast-enhanced CT of the abdomen as shown. Histopathology confirms favorable-histology Wilms tumor. According to the Children’s Oncology Group staging system, what is the most appropriate stage?
---
- (A) Stage II
- (B) Stage III
- (C) Stage IV
- (D) Stage V
💡 Click to Reveal Answer & Nelson Rationale
Option D (Stage V)
The CT image demonstrates multicentric bilateral renal masses involving both kidneys, with compression of the residual enhancing renal parenchyma. In the Children’s Oncology Group staging system, bilateral renal involvement at diagnosis is classified as Stage V Wilms tumor. This designation applies irrespective of the local extent of each renal mass and is distinct from Stage IV, which is reserved for hematogenous metastases or lymph node metastases outside the abdominopelvic region. Bilateral disease requires treatment planning that preserves renal function, commonly using preoperative chemotherapy followed by nephron-sparing surgery whenever feasible.
![[1f40f7e0_1784287649682_1784287650.png]]
A 15-year-old adolescent presents with progressive pain and swelling around the distal femur. Radiography was done as shown. Staging evaluation shows no metastatic disease. Which treatment approach is most appropriate?
---
- (A) Immediate limb-salvage surgery followed by MAP chemotherapy
- (B) Preoperative MAP radiotherapy followed by complete surgical resection and postoperative chemotherapy
- (C) Preoperative radiotherapy followed by limb-salvage surgery and chemotherapy
- (D) Preoperative MAP chemotherapy followed by complete surgical resection and postoperative chemotherapy
💡 Click to Reveal Answer & Nelson Rationale
Option D (Preoperative MAP chemotherapy followed by complete surgical resection and postoperative chemotherapy)
The radiograph shows an aggressive osteogenic tumor of the distal femur with a sunburst pattern of periosteal bone formation, consistent with conventional osteosarcoma. Standard treatment for nonmetastatic extremity osteosarcoma consists of preoperative MAP chemotherapy, complete surgical resection, and postoperative chemotherapy. MAP includes high-dose methotrexate, doxorubicin, and cisplatin. Neoadjuvant chemotherapy begins treatment of occult micrometastatic disease immediately, may facilitate limb-salvage surgery, and permits assessment of histologic response in the resected specimen. Complete surgical excision remains essential for cure, and postoperative chemotherapy should be resumed as early as feasible. With chemotherapy and surgery, the 5-year disease-free survival for nonmetastatic extremity osteosarcoma is approximately 65–75%.
A 10-year-old boy undergoes radiographic evaluation after a minor knee injury. The radiograph is shown. He has no fever, weight loss, or other constitutional symptoms, and laboratory investigations are normal. Which of the following is the most likely diagnosis?
---
- (A) Fibrous dysplasia
- (B) Chondromyxoid fibroma
- (C) Nonossifying fibroma
- (D) Unicameral bone cyst
💡 Click to Reveal Answer & Nelson Rationale
Option C (Nonossifying fibroma)
The radiograph shows a well-defined, eccentric, radiolucent lesion in the metaphysis with a thin sclerotic margin. This appearance is characteristic of a nonossifying fibroma.
Nonossifying fibroma is a common benign developmental bone lesion in children and adolescents. It is frequently discovered incidentally when radiographs are obtained after trauma. Most children are asymptomatic, and the lesion usually regresses spontaneously as skeletal maturity approaches.
The characteristic eccentric metaphyseal location helps distinguish it from lesions that are primarily central or intramedullary. In an asymptomatic child with a typical radiographic appearance, further imaging or biopsy is generally unnecessary. Observation is appropriate. Treatment with curettage and bone grafting may be considered if the lesion is painful, very large, or occupies more than approximately 50% of the bone diameter because of the risk of pathological fracture.
A 12-year-old child presents with persistent pain involving the great toe. The clinical photograph and radiographs are shown. Which of the following is the most appropriate management?
---
- (A) Oral antibiotics with complete nail avulsion and radiographic follow-up
- (B) Observation with activity modification and serial radiographs
- (C) Curettage of the lesion with bone grafting and nailbed preservation
- (D) Nailbed removal with complete surgical excision and nailbed repair
💡 Click to Reveal Answer & Nelson Rationale
Option D (Nailbed removal with complete surgical excision and nailbed repair)
The image is consistent with subungual exostosis, an osteochondromatous bony outgrowth arising beneath the nailbed. Children typically present with persistent pain, elevation or discoloration of the nail, and a firm subungual mass. Radiography demonstrates a bony protuberance arising from the distal phalanx, which distinguishes it from an ingrown toenail or paronychia. Because the lesion is usually symptomatic and mechanically distorts the nailbed, definitive treatment is complete surgical excision with removal and subsequent repair of the nailbed. Careful excision is important because incomplete removal can lead to recurrence, which occurs in up to approximately 5% of cases.
![[8738a7b7_1784288057020_1784288059.png]]
A
9-year-old boy presents with persistent bone pain for 6 weeks without a history
of trauma. Based on the common manifestations of childhood malignancies, bone
pain may result from all of the following except:<o:p
---
- (A) Acute lymphoblastic leukemia with bone marrow infiltration
- (B) Metastatic neuroblastoma involving bone
- (C) Wilms tumor
- (D) Osteosarcoma
💡 Click to Reveal Answer & Nelson Rationale
Option D (Osteosarcoma)
Persistent
bone pain in children should raise suspicion for malignancy. The major
malignant causes include acute lymphoblastic leukemia due to bone marrow
infiltration, metastatic neuroblastoma, primary bone tumors such as
osteosarcoma, and Langerhans cell histiocytosis. Wilms tumor typically presents
as an abdominal mass and is not a common cause of isolated bone pain.<o:p></o:p>
**<font color="#54acd2">
</font>**
<b><font color="#54acd2">
A
5-year-old boy is diagnosed with adrenal neuroblastoma following abdominal
imaging and histopathological confirmation. Contrast-enhanced CT and MRI have
adequately delineated the primary tumor. An investigation is required to
identify occult skeletal and soft-tissue metastatic disease that is most
specific for neuroblastoma. Which of the following is the most appropriate
investigation?<o:p
---
- (A) Technetium-99m bone scintigraphy
- (B) Fluorodeoxyglucose (FDG) PET-CT
- (C) ¹²³I-metaiodobenzylguanidine scintigraphy
- (D) Gallium-68 DOTATATE PET-CT
💡 Click to Reveal Answer & Nelson Rationale
Option C (¹²³I-metaiodobenzylguanidine scintigraphy)
¹²³I-metaiodobenzylguanidine
scintigraphy is the imaging modality of choice for staging neuroblastoma, as it
is highly specific for neural crest-derived tumors and is superior for
detecting metastatic disease involving bone, bone marrow, lymph nodes, and soft
tissues. It is an integral part of risk stratification and treatment planning
in most patients with neuroblastoma. Although other functional imaging
modalities may have complementary roles in selected situations, MIBG
scintigraphy remains the disease-specific standard investigation for metastatic
evaluation.<o:p></o:p>
**<font color="#54acd2">
</font>**
<b><font color="#54acd2">
A
12-year-old boy is diagnosed with a childhood malignancy and is undergoing
initial staging before definitive therapy. According to the recommended
diagnostic workup for common pediatric malignancies, bone marrow examination is
routinely performed in all of the following conditions except:<o:p
---
- (A) Osteosarcoma
- (B) Non-Hodgkin lymphoma
- (C) Burkitt lymphoma
- (D) Ewing sarcoma
💡 Click to Reveal Answer & Nelson Rationale
Option A (Osteosarcoma)
Bone
marrow examination is routinely performed in several pediatric malignancies to
detect marrow involvement for diagnosis or staging. It is an integral part of
the workup for Non-Hodgkin lymphoma, including Burkitt lymphoma, because bone
marrow involvement influences staging and treatment. Ewing sarcoma may also
require bone marrow evaluation as part of the staging workup according to the
Nelson diagnostic algorithm. In contrast, osteosarcoma primarily metastasizes
to the lungs and bones, and routine bone marrow examination is not recommended
as part of its initial evaluation.<o:p></o:p>
**<font color="#54acd2">
</font>**
<b><font color="#54acd2">
A
4-year-old boy is diagnosed with acute lymphoblastic leukemia (ALL). While
discussing the diagnosis, his parents mention that several relatives have had
childhood cancers, prompting evaluation for an underlying cancer predisposition
syndrome. Which of the following inherited disorders is least strongly
associated with an increased risk of childhood leukemia?<o:p
---
- (A) Fanconi anemia
- (B) Shwachman-Diamond syndrome
- (C) Neurofibromatosis type 1
- (D) Beckwith-Wiedemann syndrome
💡 Click to Reveal Answer & Nelson Rationale
Option D (Beckwith-Wiedemann syndrome)
Several
inherited disorders are associated with an increased risk of childhood leukemia
because of defects in DNA repair, bone marrow failure, or abnormalities in
hematopoiesis. These include Fanconi anemia, Shwachman-Diamond syndrome,
Neurofibromatosis type 1, Down syndrome, Bloom syndrome, Li-Fraumeni syndrome,
Diamond-Blackfan anemia, Kostmann syndrome, severe combined immunodeficiency,
and ataxia-telangiectasia. In contrast, Beckwith-Wiedemann syndrome is an
overgrowth syndrome that primarily predisposes to embryonal solid tumors,
particularly Wilms tumor, hepatoblastoma, neuroblastoma, and adrenocortical
tumors, rather than leukemia.
![[e6b782fa_large_5_36169630219b48c0b1bb51a6e2dffa4c.png]]
<o:p></o:p>
<!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600"
o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f"
stroked="f">
<v:stroke joinstyle="miter"></v:stroke>
<v:formulas>
<v:f eqn="if lineDrawn pixelLineWidth 0"></v:f>
<v:f eqn="sum @0 1 0"></v:f>
<v:f eqn="sum 0 0 @1"></v:f>
<v:f eqn="prod @2 1 2"></v:f>
<v:f eqn="prod @3 21600 pixelWidth"></v:f>
<v:f eqn="prod @3 21600 pixelHeight"></v:f>
<v:f eqn="sum @0 0 1"></v:f>
<v:f eqn="prod @6 1 2"></v:f>
<v:f eqn="prod @7 21600 pixelWidth"></v:f>
<v:f eqn="sum @8 21600 0"></v:f>
<v:f eqn="prod @7 21600 pixelHeight"></v:f>
<v:f eqn="sum @10 21600 0"></v:f>
</v:formulas>
<v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"></v:path>
<o:lock v:ext="edit" aspectratio="t"></o:lock>
</v:shapetype><v:shape id="image4.jpg" o:spid="_x0000_i1025" type="#_x0000_t75"
style='width:468pt;height:204.75pt;visibility:visible;mso-wrap-style:square'>
<v:imagedata src="file:///C:/Users/DELL/AppData/Local/Temp/msohtmlclip1/01/clip_image001.jpg"
o:title=""></v:imagedata>
</v:shape><![endif]--><!--[if !vml]--><!--[endif]--><o:p></o:p>
<b style="font-size: 12pt;"><font color="#54acd2">
A
6-year-old child presents with fever, pallor, generalized lymphadenopathy, and
hepatosplenomegaly. Bone marrow examination reveals large lymphoblasts with
intensely basophilic cytoplasm, prominent cytoplasmic vacuolation, and one or
more conspicuous nucleoli. According to the French-American-British (FAB)
classification of acute lymphoblastic leukemia, which of the following FAB
subtypes is most consistent with these morphologic findings?<o:p
---
- (A) L1
- (B) L2
- (C) L3
- (D) AML-M2
💡 Click to Reveal Answer & Nelson Rationale
Option C (L3)
The
L3 subtype of acute lymphoblastic leukemia is characterized by large,
homogeneous blasts with intensely basophilic cytoplasm, prominent cytoplasmic
vacuolation, and conspicuous nucleoli. These cells have morphologic features
similar to Burkitt lymphoma cells and correspond to mature B-cell ALL. In
contrast, L1 consists of small, homogeneous blasts with scant cytoplasm and
inconspicuous nucleoli, whereas L2 shows larger, heterogeneous blasts with
irregular nuclei and variable cytoplasm.
![[748f92e1_small_21_cbbb357a99604c9693790f4e9c49d4f2.png]]
<o:p></o:p>
<!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600"
o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f"
stroked="f">
<v:stroke joinstyle="miter"></v:stroke>
<v:formulas>
<v:f eqn="if lineDrawn pixelLineWidth 0"></v:f>
<v:f eqn="sum @0 1 0"></v:f>
<v:f eqn="sum 0 0 @1"></v:f>
<v:f eqn="prod @2 1 2"></v:f>
<v:f eqn="prod @3 21600 pixelWidth"></v:f>
<v:f eqn="prod @3 21600 pixelHeight"></v:f>
<v:f eqn="sum @0 0 1"></v:f>
<v:f eqn="prod @6 1 2"></v:f>
<v:f eqn="prod @7 21600 pixelWidth"></v:f>
<v:f eqn="sum @8 21600 0"></v:f>
<v:f eqn="prod @7 21600 pixelHeight"></v:f>
<v:f eqn="sum @10 21600 0"></v:f>
</v:formulas>
<v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"></v:path>
<o:lock v:ext="edit" aspectratio="t"></o:lock>
</v:shapetype><v:shape id="image11.jpg" o:spid="_x0000_i1025" type="#_x0000_t75"
style='width:468pt;height:126.75pt;visibility:visible;mso-wrap-style:square'>
<v:imagedata src="file:///C:/Users/DELL/AppData/Local/Temp/msohtmlclip1/01/clip_image001.jpg"
o:title=""></v:imagedata>
</v:shape><![endif]--><!--[if !vml]--><!--[endif]--><o:p></o:p>
<b style="font-size: 12pt;"><font color="#54acd2">
A
5-year-old boy is diagnosed with precursor B-cell acute lymphoblastic leukemia.
Flow cytometry demonstrates expression of CD19 and CD10 on the leukemic blasts.
Which of the following best describes the prognostic significance of this
immunophenotype?<o:p
---
- (A) Associated with mixed-lineage leukemia and poor prognosis
- (B) Associated with favorable prognosis
- (C) Suggestive of mature B-cell ALL requiring intensified therapy
- (D) Predictive of increased risk of central nervous system leukemia
💡 Click to Reveal Answer & Nelson Rationale
Option B (Associated with favorable prognosis)
Expression
of CD10 and CD19 is characteristic of precursor B-cell ALL and is associated
with a favorable prognosis. In contrast, absence of CD10 is associated with KMT2A
(MLL)-rearranged leukemia, particularly t(4;11), and carries a poorer
prognosis.
![[46f507f2_medium_12_5bb543ce977d48cfa96c7b1cdccac065.png]]
<o:p></o:p>
<!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600"
o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f"
stroked="f">
<v:stroke joinstyle="miter"></v:stroke>
<v:formulas>
<v:f eqn="if lineDrawn pixelLineWidth 0"></v:f>
<v:f eqn="sum @0 1 0"></v:f>
<v:f eqn="sum 0 0 @1"></v:f>
<v:f eqn="prod @2 1 2"></v:f>
<v:f eqn="prod @3 21600 pixelWidth"></v:f>
<v:f eqn="prod @3 21600 pixelHeight"></v:f>
<v:f eqn="sum @0 0 1"></v:f>
<v:f eqn="prod @6 1 2"></v:f>
<v:f eqn="prod @7 21600 pixelWidth"></v:f>
<v:f eqn="sum @8 21600 0"></v:f>
<v:f eqn="prod @7 21600 pixelHeight"></v:f>
<v:f eqn="sum @10 21600 0"></v:f>
</v:formulas>
<v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"></v:path>
<o:lock v:ext="edit" aspectratio="t"></o:lock>
</v:shapetype><v:shape id="image10.jpg" o:spid="_x0000_i1025" type="#_x0000_t75"
style='width:468pt;height:141.75pt;visibility:visible;mso-wrap-style:square'>
<v:imagedata src="file:///C:/Users/DELL/AppData/Local/Temp/msohtmlclip1/01/clip_image001.jpg"
o:title=""></v:imagedata>
</v:shape><![endif]--><!--[if !vml]--><!--[endif]--><o:p></o:p>
<b style="font-size: 12pt;"><font color="#54acd2">
A
9-year-old boy presents with a 2-week history of fever, fatigue, and easy
bruising. On examination, he has pallor and multiple petechiae. Laboratory
evaluation reveals pancytopenia with circulating blasts, prolonged prothrombin
time, prolonged activated partial thromboplastin time, low fibrinogen, and
markedly elevated D-dimer levels. Which of the following leukemia subtypes
should be suspected first?<o:p
---
- (A) Acute lymphoblastic leukemia
- (B) Chronic myeloid leukemia
- (C) Acute promyelocytic leukemia
- (D) Juvenile myelomonocytic leukemia
💡 Click to Reveal Answer & Nelson Rationale
Option C (Acute promyelocytic leukemia)
Acute
promyelocytic leukemia (APL, FAB M3) is a distinct subtype of AML that is
strongly associated with disseminated intravascular coagulation (DIC) due to
the release of procoagulant substances from abnormal promyelocytes. Patients
often present with severe bleeding manifestations, and coagulopathy may be
life-threatening. Recognition of APL is critical because treatment with all-trans
retinoic acid (ATRA) should be initiated promptly, even before cytogenetic
confirmation, when clinical suspicion is high.
![[3ec3c282_small_22_9b8fb7a7b1fc47938de60fa1d1f71e98.png]]
<o:p></o:p>
<!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600"
o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f"
stroked="f">
<v:stroke joinstyle="miter"></v:stroke>
<v:formulas>
<v:f eqn="if lineDrawn pixelLineWidth 0"></v:f>
<v:f eqn="sum @0 1 0"></v:f>
<v:f eqn="sum 0 0 @1"></v:f>
<v:f eqn="prod @2 1 2"></v:f>
<v:f eqn="prod @3 21600 pixelWidth"></v:f>
<v:f eqn="prod @3 21600 pixelHeight"></v:f>
<v:f eqn="sum @0 0 1"></v:f>
<v:f eqn="prod @6 1 2"></v:f>
<v:f eqn="prod @7 21600 pixelWidth"></v:f>
<v:f eqn="sum @8 21600 0"></v:f>
<v:f eqn="prod @7 21600 pixelHeight"></v:f>
<v:f eqn="sum @10 21600 0"></v:f>
</v:formulas>
<v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"></v:path>
<o:lock v:ext="edit" aspectratio="t"></o:lock>
</v:shapetype><v:shape id="image3.jpg" o:spid="_x0000_i1025" type="#_x0000_t75"
style='width:468pt;height:288.75pt;visibility:visible;mso-wrap-style:square'>
<v:imagedata src="file:///C:/Users/DELL/AppData/Local/Temp/msohtmlclip1/01/clip_image001.jpg"
o:title=""></v:imagedata>
</v:shape><![endif]--><!--[if !vml]--><!--[endif]--><o:p></o:p>
<b style="font-size: 12pt;"><font color="#54acd2">
A
3-year-old boy presents with fever, hepatosplenomegaly, and leukocytosis with
marked monocytosis. Bone marrow examination shows granulocytic precursors at
all stages of maturation, and fetal hemoglobin is elevated. Which of the
following cytogenetic abnormalities is most likely to be present?<o:p
---
- (A) Philadelphia chromosome [t(9;22)]
- (B) Monosomy 7
- (C) t(15;17)
- (D) t(8;21)
💡 Click to Reveal Answer & Nelson Rationale
Option B (Monosomy 7)
The
child has features suggestive of juvenile myelomonocytic leukemia (JMML),
including presentation before 5 years of age, hepatosplenomegaly, leukocytosis
with marked monocytosis, elevated fetal hemoglobin (HbF), and bone marrow
showing granulocytic cells at all stages of maturation. JMML is a mixed
myelodysplastic/myeloproliferative neoplasm that is Philadelphia
chromosome-negative. Approximately 30% of patients with JMML harbor monosomy 7,
making it the characteristic cytogenetic abnormality associated with this
disease.<o:p></o:p>
**<font color="#54acd2">
</font>**
<b><font color="#54acd2">
A
12-year-old boy presents with a 3-week history of abdominal pain and
progressive cervical lymphadenopathy. Contrast-enhanced CT confirms the
diagnosis of lymphoma. Which of the following additional findings would most
strongly favor non-Hodgkin lymphoma rather than Hodgkin lymphoma?<o:p
---
- (A) Contiguous spread to adjacent lymph node groups
- (B) Localized nodal disease with B symptoms
- (C) Central nervous system involvement at presentation
- (D) Histologic subtype has little influence on treatment
💡 Click to Reveal Answer & Nelson Rationale
Option C (Central nervous system involvement at presentation)
Childhood
non-Hodgkin lymphoma (NHL) is characterized by rapid progression, discontinuous
nodal spread, and a higher frequency of extranodal involvement, including the central
nervous system (CNS) and bone marrow. CNS involvement at presentation is
uncommon in Hodgkin lymphoma and strongly favors NHL. In addition, abdominal
disease is common in NHL, and treatment is highly dependent on the histological
subtype.
![[ae898ce2_small_23_40e2a80db8414e7283f010275f577a63.png]]
<o:p></o:p>
<!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600"
o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f"
stroked="f">
<v:stroke joinstyle="miter"></v:stroke>
<v:formulas>
<v:f eqn="if lineDrawn pixelLineWidth 0"></v:f>
<v:f eqn="sum @0 1 0"></v:f>
<v:f eqn="sum 0 0 @1"></v:f>
<v:f eqn="prod @2 1 2"></v:f>
<v:f eqn="prod @3 21600 pixelWidth"></v:f>
<v:f eqn="prod @3 21600 pixelHeight"></v:f>
<v:f eqn="sum @0 0 1"></v:f>
<v:f eqn="prod @6 1 2"></v:f>
<v:f eqn="prod @7 21600 pixelWidth"></v:f>
<v:f eqn="sum @8 21600 0"></v:f>
<v:f eqn="prod @7 21600 pixelHeight"></v:f>
<v:f eqn="sum @10 21600 0"></v:f>
</v:formulas>
<v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"></v:path>
<o:lock v:ext="edit" aspectratio="t"></o:lock>
</v:shapetype><v:shape id="image8.jpg" o:spid="_x0000_i1025" type="#_x0000_t75"
style='width:468pt;height:159pt;visibility:visible;mso-wrap-style:square'>
<v:imagedata src="file:///C:/Users/DELL/AppData/Local/Temp/msohtmlclip1/01/clip_image001.jpg"
o:title=""></v:imagedata>
</v:shape><![endif]--><!--[if !vml]--><!--[endif]--><o:p></o:p>
<b style="font-size: 12pt;"><font color="#54acd2">
A
16-month-old boy is brought with leukocoria involving both eyes. Fundus
examination reveals multiple retinal masses in each eye, and retinoblastoma is
confirmed. There is no family history of retinoblastoma. Which of the following
clinical features most strongly favors hereditary retinoblastoma over the
non-hereditary form?<o:p
---
- (A) Unilateral, unifocal retinal tumor
- (B) Bilateral, multifocal retinal tumors
- (C) Increased risk of second primary malignancies later in life
- (D) De novo somatic RB1 mutation confined to retinal cells
💡 Click to Reveal Answer & Nelson Rationale
Option B (Bilateral, multifocal retinal tumors)
Hereditary
retinoblastoma results from a germline RB1 mutation, which may be inherited
from an affected parent or occur as a de novo mutation in a parental gamete or
shortly after fertilization. Because the mutation is present in all cells of
the body, affected children typically develop bilateral, multifocal retinal
tumors at an early age. Although hereditary retinoblastoma is associated with
an increased lifetime risk of second primary malignancies, the most
characteristic clinical feature distinguishing it from the non-hereditary form
is bilateral, multifocal disease.
![[fe3d7a89_image_5fda34d12ab342fc8bf3c3c07586e62a.png]]
****<o:p></o:p>
**<font color="#54acd2">
</font>**
<b><font color="#54acd2">
Which
of the following syndrome–brain tumor associations is incorrect?<o:p
---
- (A) Neurofibromatosis type 1 — Optic glioma
- (B) Turcot syndrome — Medulloblastoma
- (C) Tuberous sclerosis — Subependymal giant cell astrocytoma
- (D) Li-Fraumeni syndrome — Medulloblastoma
💡 Click to Reveal Answer & Nelson Rationale
Option D (Li-Fraumeni syndrome — Medulloblastoma)
Several
inherited cancer predisposition syndromes are associated with characteristic
brain tumors. Neurofibromatosis type 1 (NF1) is associated with optic glioma,
Tuberous sclerosis with subependymal giant cell astrocytoma (SEGA), and Turcot
syndrome with medulloblastoma or malignant glioma. Li-Fraumeni syndrome, caused
by germline TP53 mutations, is classically associated with choroid plexus
carcinoma, rather than medulloblastoma.
![[f9c31d24_small_24_2d4b1df0f7ab49bb9a05462fc918251f.png]]
<o:p></o:p>
<!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600"
o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f"
stroked="f">
<v:stroke joinstyle="miter"></v:stroke>
<v:formulas>
<v:f eqn="if lineDrawn pixelLineWidth 0"></v:f>
<v:f eqn="sum @0 1 0"></v:f>
<v:f eqn="sum 0 0 @1"></v:f>
<v:f eqn="prod @2 1 2"></v:f>
<v:f eqn="prod @3 21600 pixelWidth"></v:f>
<v:f eqn="prod @3 21600 pixelHeight"></v:f>
<v:f eqn="sum @0 0 1"></v:f>
<v:f eqn="prod @6 1 2"></v:f>
<v:f eqn="prod @7 21600 pixelWidth"></v:f>
<v:f eqn="sum @8 21600 0"></v:f>
<v:f eqn="prod @7 21600 pixelHeight"></v:f>
<v:f eqn="sum @10 21600 0"></v:f>
</v:formulas>
<v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"></v:path>
<o:lock v:ext="edit" aspectratio="t"></o:lock>
</v:shapetype><v:shape id="image7.jpg" o:spid="_x0000_i1025" type="#_x0000_t75"
style='width:468pt;height:153pt;visibility:visible;mso-wrap-style:square'>
<v:imagedata src="file:///C:/Users/DELL/AppData/Local/Temp/msohtmlclip1/01/clip_image001.jpg"
o:title=""></v:imagedata>
</v:shape><![endif]--><!--[if !vml]--><!--[endif]--><o:p></o:p>
<b style="font-size: 12pt;"><font color="#54acd2">
A
6-year-old boy is newly diagnosed with precursor B-cell acute lymphoblastic
leukemia (ALL). Cytogenetic analysis is performed for risk stratification
before initiation of therapy. Which of the following cytogenetic abnormalities
is associated with the least favorable prognosis?<o:p
---
- (A) Hyperdiploidy (>50 chromosomes)
- (B) ETV6-RUNX1 fusion
- (C) BCR-ABL1 (Philadelphia chromosome)
- (D) Trisomy 4 and 10
💡 Click to Reveal Answer & Nelson Rationale
Option C (BCR-ABL1 (Philadelphia chromosome))
Cytogenetic
abnormalities are among the most important prognostic determinants in childhood
ALL. The BCR-ABL1 (Philadelphia chromosome) translocation is associated with very
high-risk disease and an adverse prognosis. Although outcomes have improved
with the addition of tyrosine kinase inhibitors such as imatinib, this
abnormality continues to identify a high-risk subgroup requiring intensified
therapy.
![[235e8622_large_6_48233d58138641d584ee79ea8e5d4751.png]]
<o:p></o:p>
<!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600"
o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f"
stroked="f">
<v:stroke joinstyle="miter"></v:stroke>
<v:formulas>
<v:f eqn="if lineDrawn pixelLineWidth 0"></v:f>
<v:f eqn="sum @0 1 0"></v:f>
<v:f eqn="sum 0 0 @1"></v:f>
<v:f eqn="prod @2 1 2"></v:f>
<v:f eqn="prod @3 21600 pixelWidth"></v:f>
<v:f eqn="prod @3 21600 pixelHeight"></v:f>
<v:f eqn="sum @0 0 1"></v:f>
<v:f eqn="prod @6 1 2"></v:f>
<v:f eqn="prod @7 21600 pixelWidth"></v:f>
<v:f eqn="sum @8 21600 0"></v:f>
<v:f eqn="prod @7 21600 pixelHeight"></v:f>
<v:f eqn="sum @10 21600 0"></v:f>
</v:formulas>
<v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"></v:path>
<o:lock v:ext="edit" aspectratio="t"></o:lock>
</v:shapetype><v:shape id="image12.jpg" o:spid="_x0000_i1025" type="#_x0000_t75"
style='width:467.25pt;height:240.75pt;visibility:visible;mso-wrap-style:square'>
<v:imagedata src="file:///C:/Users/DELL/AppData/Local/Temp/msohtmlclip1/01/clip_image001.jpg"
o:title=""></v:imagedata>
</v:shape><![endif]--><!--[if !vml]--><!--[endif]--><o:p></o:p>
<b style="font-size: 12pt;"><font color="#54acd2">
A
7-year-old boy is evaluated for suspected hemophagocytic lymphohistiocytosis
(HLH). He has persistent fever, splenomegaly, bicytopenia, and
hypertriglyceridemia. According to the HLH-2004 diagnostic criteria, which of
the following combinations of laboratory cut-off values is correct?<o:p
---
- (A) Fasting triglycerides >265 mg/dL, fibrinogen <1.5 g/L, ferritin >500 µg/L, soluble CD25 >2400 U/mL
- (B) Fasting triglycerides >200 mg/dL, fibrinogen <2.0 g/L, ferritin >1000 µg/L, soluble CD25 >5000 U/mL
- (C) Fasting triglycerides >300 mg/dL, fibrinogen <1.0 g/L, ferritin >1000 µg/L, soluble CD25 >2400 U/mL
- (D) Fasting triglycerides >265 mg/dL, fibrinogen <2.0 g/L, ferritin >1000 µg/L, soluble CD25 >5000 U/mL
💡 Click to Reveal Answer & Nelson Rationale
Option A (Fasting triglycerides >265 mg/dL, fibrinogen <1.5 g/L, ferritin >500 µg/L, soluble CD25 >2400 U/mL)
According
to the HLH-2004 diagnostic criteria, HLH is diagnosed by either identifying a
pathogenic molecular mutation or fulfilling 5 of the 8 diagnostic criteria. The
laboratory thresholds include fasting triglycerides >3 mmol/L (>265
mg/dL), fibrinogen <1.5 g/L, serum ferritin >500 µg/L, and soluble CD25
(soluble IL-2 receptor) >2400 U/mL. These cut-off values are frequently
tested in pediatric hematology examinations.
![[072ac04a_small_25_888c9e285e1a4d65bd29c3ed88aac891.png]]
<o:p></o:p>
<!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600"
o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f"
stroked="f">
<v:stroke joinstyle="miter"></v:stroke>
<v:formulas>
<v:f eqn="if lineDrawn pixelLineWidth 0"></v:f>
<v:f eqn="sum @0 1 0"></v:f>
<v:f eqn="sum 0 0 @1"></v:f>
<v:f eqn="prod @2 1 2"></v:f>
<v:f eqn="prod @3 21600 pixelWidth"></v:f>
<v:f eqn="prod @3 21600 pixelHeight"></v:f>
<v:f eqn="sum @0 0 1"></v:f>
<v:f eqn="prod @6 1 2"></v:f>
<v:f eqn="prod @7 21600 pixelWidth"></v:f>
<v:f eqn="sum @8 21600 0"></v:f>
<v:f eqn="prod @7 21600 pixelHeight"></v:f>
<v:f eqn="sum @10 21600 0"></v:f>
</v:formulas>
<v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"></v:path>
<o:lock v:ext="edit" aspectratio="t"></o:lock>
</v:shapetype><v:shape id="image2.jpg" o:spid="_x0000_i1025" type="#_x0000_t75"
style='width:412.5pt;height:377.25pt;visibility:visible;mso-wrap-style:square'>
<v:imagedata src="file:///C:/Users/DELL/AppData/Local/Temp/msohtmlclip1/01/clip_image001.jpg"
o:title=""></v:imagedata>
</v:shape><![endif]--><!--[if !vml]--><!--[endif]--><o:p></o:p>
<b style="font-size: 12pt;"><font color="#54acd2">
A
7-year-old boy is diagnosed with acute myeloid leukemia (AML) after bone marrow
examination. Cytogenetic and molecular studies are performed to determine his
prognostic risk category and guide treatment. Which of the following genetic
abnormalities is classified as an adverse-risk lesion in childhood AML?<o:p
---
- (A) inv(16)(p13.1;q22); CBFB-MYH11
- (B) Biallelic CEBPA mutation
- (C) Mutated NPM1 without FLT3-ITDhigh
- (D) t(9;22)(q34.1;q11.2); BCR-ABL1
💡 Click to Reveal Answer & Nelson Rationale
Option D (t(9;22)(q34.1;q11.2); BCR-ABL1)
Risk
stratification in childhood AML is primarily based on cytogenetic and molecular
abnormalities. BCR-ABL1 [t(9;22)] is classified as an adverse-risk genetic
lesion and is associated with poor clinical outcomes. Other adverse-risk
abnormalities include KMT2A rearrangements, DEK-NUP214, complex or monosomal
karyotype, mutated TP53, mutated RUNX1, and mutated ASXL1. Identification of
these abnormalities is essential for risk-adapted therapy and consideration of
hematopoietic stem cell transplantation.
![[c4596efd_small_26_271f0f085448434fb3a6b0b3d1f55e70.png]]
<o:p></o:p>
<!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600"
o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f"
stroked="f">
<v:stroke joinstyle="miter"></v:stroke>
<v:formulas>
<v:f eqn="if lineDrawn pixelLineWidth 0"></v:f>
<v:f eqn="sum @0 1 0"></v:f>
<v:f eqn="sum 0 0 @1"></v:f>
<v:f eqn="prod @2 1 2"></v:f>
<v:f eqn="prod @3 21600 pixelWidth"></v:f>
<v:f eqn="prod @3 21600 pixelHeight"></v:f>
<v:f eqn="sum @0 0 1"></v:f>
<v:f eqn="prod @6 1 2"></v:f>
<v:f eqn="prod @7 21600 pixelWidth"></v:f>
<v:f eqn="sum @8 21600 0"></v:f>
<v:f eqn="prod @7 21600 pixelHeight"></v:f>
<v:f eqn="sum @10 21600 0"></v:f>
</v:formulas>
<v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"></v:path>
<o:lock v:ext="edit" aspectratio="t"></o:lock>
</v:shapetype><v:shape id="image6.jpg" o:spid="_x0000_i1025" type="#_x0000_t75"
style='width:468pt;height:225pt;visibility:visible;mso-wrap-style:square'>
<v:imagedata src="file:///C:/Users/DELL/AppData/Local/Temp/msohtmlclip1/01/clip_image001.jpg"
o:title=""></v:imagedata>
</v:shape><![endif]--><!--[if !vml]--><!--[endif]--><o:p></o:p>
<b style="font-size: 12pt;"><font color="#54acd2">
A
12-year-old boy with Burkitt lymphoma develops oliguria and a rapidly rising
serum creatinine 24 hours after initiation of induction chemotherapy.
Laboratory evaluation reveals hyperkalemia, hyperphosphatemia, hypocalcemia,
and markedly elevated serum uric acid. Which of the following interventions is
most appropriate to prevent further renal injury?<o:p
---
- (A) Aggressive intravenous hydration with rasburicase
- (B) Urinary alkalinization with sodium bicarbonate alone
- (C) Intravenous calcium gluconate as definitive therapy
- (D) Forced diuresis with furosemide
💡 Click to Reveal Answer & Nelson Rationale
Option A (Aggressive intravenous hydration with rasburicase)
The
child has tumor lysis syndrome (TLS) complicated by acute uric acid nephropathy.
Rapid destruction of malignant cells releases purines, which are metabolized to
uric acid, leading to intratubular crystal deposition and acute kidney injury.
The cornerstone of management is aggressive intravenous hydration combined with
rasburicase, which rapidly degrades uric acid to the more soluble allantoin.
Early treatment minimizes further renal injury.<o:p></o:p>
**<font color="#54acd2">
</font>**
<b><font color="#54acd2">
A
10-year-old boy with Burkitt lymphoma develops tumor lysis syndrome 24 hours
after initiation of induction chemotherapy. Which of the following electrolyte
abnormalities is not classically associated with tumor lysis syndrome?<o:p
---
- (A) Hyperphosphatemia
- (B) Hyperkalemia
- (C) Hyponatremia
- (D) Hypocalcemia
💡 Click to Reveal Answer & Nelson Rationale
Option C (Hyponatremia)
Tumor
lysis syndrome (TLS) results from rapid destruction of malignant cells, leading
to the release of intracellular potassium, phosphate, and nucleic acids into
the circulation. The characteristic metabolic abnormalities are hyperkalemia,
hyperphosphatemia, hyperuricemia, and secondary hypocalcemia due to
calcium-phosphate precipitation. Hyponatremia is not a characteristic feature
of TLS and should prompt evaluation for other causes such as SIADH or excessive
free water administration.
![[d2511c0e_large_7_bc00f0358d23413d8de7a21f2407b40c.png]]
<o:p></o:p>
<!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600"
o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f"
stroked="f">
<v:stroke joinstyle="miter"></v:stroke>
<v:formulas>
<v:f eqn="if lineDrawn pixelLineWidth 0"></v:f>
<v:f eqn="sum @0 1 0"></v:f>
<v:f eqn="sum 0 0 @1"></v:f>
<v:f eqn="prod @2 1 2"></v:f>
<v:f eqn="prod @3 21600 pixelWidth"></v:f>
<v:f eqn="prod @3 21600 pixelHeight"></v:f>
<v:f eqn="sum @0 0 1"></v:f>
<v:f eqn="prod @6 1 2"></v:f>
<v:f eqn="prod @7 21600 pixelWidth"></v:f>
<v:f eqn="sum @8 21600 0"></v:f>
<v:f eqn="prod @7 21600 pixelHeight"></v:f>
<v:f eqn="sum @10 21600 0"></v:f>
</v:formulas>
<v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"></v:path>
<o:lock v:ext="edit" aspectratio="t"></o:lock>
</v:shapetype><v:shape id="image1.jpg" o:spid="_x0000_i1025" type="#_x0000_t75"
style='width:468pt;height:305.25pt;visibility:visible;mso-wrap-style:square'>
<v:imagedata src="file:///C:/Users/DELL/AppData/Local/Temp/msohtmlclip1/01/clip_image001.jpg"
o:title=""></v:imagedata>
</v:shape><![endif]--><!--[if !vml]--><!--[endif]--><o:p></o:p>
<b style="font-size: 12pt;"><font color="#54acd2">
A
13-year-old boy with newly diagnosed T-cell acute lymphoblastic leukemia
presents with progressive dyspnea, facial swelling, distended neck veins, and
cyanosis. Chest radiograph reveals a large anterior mediastinal mass. Which
oncologic emergency is the most likely diagnosis?<o:p
---
## 📖 Reference Citations & Explanations
- (A) Tracheal compression
- (B) Superior vena cava syndrome
- (C) Hyperleukocytosis
- (D) Increased intracranial pressure
💡 Click to Reveal Answer & Nelson Rationale
Option B (Superior vena cava syndrome)
Superior
vena cava (SVC) syndrome results from compression of the superior vena cava by
an anterior mediastinal mass, most commonly due to lymphoma or mediastinal germ
cell tumors in children. The classical features include facial and neck edema,
distended neck veins, plethora, cyanosis, and dyspnea. Prompt chemotherapy
and/or radiotherapy is required.
![[fa7a5fc8_large_8_9b8f7bd03987473c940a4d60114d2b1c.png]]
<o:p></o:p>
<!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600"
o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f"
stroked="f">
<v:stroke joinstyle="miter"></v:stroke>
<v:formulas>
<v:f eqn="if lineDrawn pixelLineWidth 0"></v:f>
<v:f eqn="sum @0 1 0"></v:f>
<v:f eqn="sum 0 0 @1"></v:f>
<v:f eqn="prod @2 1 2"></v:f>
<v:f eqn="prod @3 21600 pixelWidth"></v:f>
<v:f eqn="prod @3 21600 pixelHeight"></v:f>
<v:f eqn="sum @0 0 1"></v:f>
<v:f eqn="prod @6 1 2"></v:f>
<v:f eqn="prod @7 21600 pixelWidth"></v:f>
<v:f eqn="sum @8 21600 0"></v:f>
<v:f eqn="prod @7 21600 pixelHeight"></v:f>
<v:f eqn="sum @10 21600 0"></v:f>
</v:formulas>
<v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"></v:path>
<o:lock v:ext="edit" aspectratio="t"></o:lock>
</v:shapetype><v:shape id="image9.jpg" o:spid="_x0000_i1025" type="#_x0000_t75"
style='width:468pt;height:337.5pt;visibility:visible;mso-wrap-style:square'>
<v:imagedata src="file:///C:/Users/DELL/AppData/Local/Temp/msohtmlclip1/01/clip_image001.jpg"
o:title=""></v:imagedata>
</v:shape><![endif]--><!--[if !vml]--><!--[endif]--><o:p></o:p>
<b style="font-size: 12pt;"><font color="#54acd2">